Section 10

EurekaMag PDF full texts Chapter 9,516


Basic, N.; Basic, V.; Bulic, K.; Grgic, M.; Kleinman, H.K.; Luyten, F.P.; Vukicevic, S. 1996: TGF-beta and basement membrane matrigel stimulate the chondrogenic phenotype in osteoblastic cells derived from fetal rat calvaria. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 11(3): 384-391
Heberden, C.; Denis, I.; Pointillart, A.; Mercier, T. 1998: TGF-beta and calcitriol. General Pharmacology 30(2): 145-151
Gamble, J.R.; Bradley, S.; Noack, L.; Vadas, M.A. 1995: TGF-beta and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells. Arteriosclerosis Thrombosis and Vascular Biology 15(7): 949-955
Kitamura, M.; Sütö, T.S. 1997: TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 12(4): 669-679
Frishberg, Y.; Kelly, C.J. 1998: TGF-beta and regulation of interstitial nephritis. Mineral and Electrolyte Metabolism 24(2-3): 181-189
Cui, S. 1993: TGF-beta and tenascin do not coexist in human fibrotic liver and hepatocellular carcinoma. Mie Medical Journal 43(1): 17-22
Pintavorn, P.; Ballermann, B.J. 1997: TGF-beta and the endothelium during immune injury. Kidney International 51(5): 1401-1412
Mitaka, T.; Kojima, T.; Norioka, K.; Mochizuki, Y. 1995: TGF-beta completely blocks the formation of small-cell colonies: effects of mito-inhibitory factors on the proliferation of primary cultured rat hepatocytes. Cell Structure and Function 20(2): 167-176
Maeda, H.; Shiraishi, A. 1996: TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. Journal of Immunology 156(1): 73-78
Maeda, H.; Kuwahara, H.; Ichimura, Y.; Ohtsuki, M.; Kurakata, S.; Shiraishi, A. 1995: TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. Journal of Immunology 155(10): 4926-4932
Avery, A.; Paraskeva, C.; Hall, P.; Flanders, K.C.; Sporn, M.; Moorghen, M. 1993: TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. British Journal of Cancer 68(1): 137-139
Shankland, S.J.; Johnson, R.J. 1998: TGF-beta in glomerular disease. Mineral and Electrolyte Metabolism 24(2-3): 168-173
Cohen, A.H.; Nast, C.C. 1998: TGF-beta in renal allograft rejection. Mineral and Electrolyte Metabolism 24(2-3): 197-201
Basile, D.P.; Hammerman, M.R. 1998: TGF-beta in renal development and renal growth. Mineral and Electrolyte Metabolism 24(2-3): 144-148
Miettinen, P.J.; Ebner, R.; Lopez, A.R.; Derynck, R. 1994: TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. Journal of Cell Biology 127(6 Pt 2): 2021-2036
Höfler, P.; Wehrle, I.; Bauer, G. 1993: TGF-beta induces an inhibitory effect of normal cells directed against transformed cells. International Journal of Cancer 54(1): 125-130
Takeshita, A.; Chen, Y.; Watanabe, A.; Kitano, S.; Hanazawa, S. 1995: TGF-beta induces expression of monocyte chemoattractant JE/monocyte chemoattractant protein 1 via transcriptional factor AP-1 induced by protein kinase in osteoblastic cells. Journal of Immunology 155(1): 419-426
Buske, C.; Becker, D.; Feuring-Buske, M.; Hannig, H.; Wulf, G.; Schäfer, C.; Hiddemann, W.; Wörmann, B. 1997: TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors. Leukemia 11(3): 386-392
Bombara, C.; Ignotz, R.A. 1992: TGF-beta inhibits proliferation of and promotes differentiation of human promonocytic leukemia cells. Journal of Cellular Physiology 153(1): 30-37
Spaccapelo, R.; Romani, L.; Tonnetti, L.; Cenci, E.; Mencacci, A.; Del Sero, G.; Tognellini, R.; Reed, S.G.; Puccetti, P.; Bistoni, F. 1995: TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. Journal of Immunology 155(3): 1349-1360
Eckert, S.; Bauer, G. 1998: TGF-beta isoforms and fibroblast growth factor exhibit analogous indirect antioncogenic activity through triggering of intercellular induction of apoptosis. Anticancer Research 18(1a): 45-52
Lee, M.; Hwang, C.; Lee, J.; Slavkin, H.; Warburton, D. 1997: TGF-beta isoforms differentially attenuate EGF mitogenicity and receptor activity in fetal lung mesenchymal cells. American Journal of Physiology 273(2 Part 1): L374-L381
Collier, A.J.; Elsegood, K.A.; Yeudall, W.A.; Paterson, I.C.; Prime, S.S.; Sandy, J.R. 1996: TGF-beta isoforms fail to modulate inositol phosphates and cAMP in normal and tumour-derived human oral keratinocytes. Biochimica et Biophysica Acta 1315(2): 117-122
Santos, R.M.; Norton, P.; Degli Esposti, S.; Zern, M.A. 1998: TGF-beta isoforms in alcoholic liver disease. Journal of Gastroenterology 33(3): 383-389
Letterio, J.J.; Böttinger, E.P. 1998: TGF-beta knockout and dominant-negative receptor transgenic mice. Mineral and Electrolyte Metabolism 24(2-3): 161-167
Gleizes, P.E.; Munger, J.S.; Nunes, I.; Harpel, J.G.; Mazzieri, R.; Noguera, I.; Rifkin, D.B. 1997: TGF-beta latency: biological significance and mechanisms of activation. Stem Cells 15(3): 190-197
Seremetis, G.M.; Maizels, M. 1996: TGF-beta mRNA expression in the renal pelvis after experimental and clinical ureteropelvic junction obstruction. Journal of Urology 156(1): 261-266
Flørenes, V.A.; Bhattacharya, N.; Bani, M.R.; Ben-David, Y.; Kerbel, R.S.; Slingerland, J.M. 1996: TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Oncogene 13(11): 2447-2457
Yamamoto, H.; Hirayama, M.; Genyea, C.; Kaplan, J. 1994: TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes. Journal of Immunology 152(8): 3842-3847
Nugent, P.; Potchinsky, M.; Lafferty, C.; Greene, R.M. 1995: TGF-beta modulates the expression of retinoic acid-induced RAR-beta in primary cultures of embryonic palate cells. Experimental Cell Research 220(2): 495-500
Heimer, R.; Bashey, R.I.; Kyle, J.; Jimenez, S.A. 1995: TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture. Journal of Molecular and Cellular Cardiology 27(10): 2191-2198
Barbera, Caterina; Di Bella, Gloria; La Rosa, Marzia; Ferlazzo, Viviana; Chifari, Nadia; Salvaggio, Caterina; Zambito, Liana; Ferrara, Domenico; Ferrante Bannera, Antonio; D'agostino, Pietro; Arcoleo, Francesco 1998: TGF-beta production by peripheral blood mononuclear cells in patients with visceral leishmaniasis. Giornale Italiano di Malattie Infettive 4(1): 25-28
Stouffer, G.A.; Owens, G.K. 1994: TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. Journal of Clinical Investigation 93(5): 2048-2055
Tam, B.Y.; Germain, L.; Philip, A. 1998: TGF-beta receptor expression on human keratinocytes: a 150 kDa GPI-anchored TGF-beta1 binding protein forms a heteromeric complex with type I and type II receptors. Journal of Cellular Biochemistry 70(4): 573-586
Prime, S.S.; Matthews, J.B.; Patel, V.; Game, S.M.; Donnelly, M.; Stone, A.; Paterson, I.C.; Sandy, J.R.; Yeudall, W.A. 1994: TGF-beta receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellular differentiation in human oral keratinocytes. International Journal of Cancer 56(3): 406-412
Oshima, M.; Oshima, H.; Taketo, M.M. 1996: TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Developmental Biology 179(1): 297-302
Miyazono, K. 1997: TGF-beta receptors and signal transduction. International Journal of Hematology 65(2): 97-104
Wrana, J.L. 1998: TGF-beta receptors and signalling mechanisms. Mineral and Electrolyte Metabolism 24(2-3): 120-130
Mercier, T.; Gaillard-Sanchez, I.; Martel, P.; Heberden, C. 1996: TGF-beta receptors are diminished after retinoid exposure in rat liver epithelial cells. Journal of Cellular Biochemistry 61(2): 230-237
Lin, H.Y.; Moustakas, A. 1994: TGF-beta receptors: structure and function. Cellular and Molecular Biology 40(3): 337-349
Zhao, Y.; Young, S.L. 1995: TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. American Journal of Physiology 268(2 Pt 1): L173-L180
Finder, J.; Stark, W.W.; Nakayama, D.K.; Geller, D.; Wasserloos, K.; Pitt, B.R.; Davies, P. 1995: TGF-beta regulates production of NO in pulmonary artery smooth muscle cells by inhibiting expression of NOS. American Journal of Physiology 268(5 Part 1): L862-L867
Frey, R.S.; Mulder, K.M. 1997: TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. Cancer Letters 117(1): 41-50
Subramaniam, M.; Oursler, M.J.; Rasmussen, K.; Riggs, B.L.; Spelsberg, T.C. 1995: TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells. Journal of Cellular Biochemistry 57(1): 52-61
Blottner, D.; Wolf, N.; Lachmund, A.; Flanders, K.C.; Unsicker, K. 1996: TGF-beta rescues target-deprived preganglionic sympathetic neurons in the spinal cord. European Journal of Neuroscience 8(1): 202-210
Potchinsky, M.B.; Weston, W.M.; Lloyd, M.R.; Greene, R.M. 1997: TGF-beta signaling in murine embryonic palate cells involves phosphorylation of the CREB transcription factor. Experimental Cell Research 231(1): 96-103
Haberstroh, U.; Zahner, G.; Disser, M.; Thaiss, F.; Wolf, G.; Stahl, R.A. 1993: TGF-beta stimulates rat mesangial cell proliferation in culture: role of PDGF beta-receptor expression. American Journal of Physiology 264(2 Pt 2): F199-F205
Krieglstein, K.; Suter-Crazzolara, C.; Fischer, W.H.; Unsicker, K. 1995: TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO Journal 14(4): 736-742
Liu, A.; Ballermann, B.J. 1998: TGF-beta type Ii receptor in rat renal vascular development: localization to juxtaglomerular cells. Kidney International 53(3): 716-725
Osawa, H.; Yamabe, H.; Inuma, H.; Miyata, M.; Sasaki, T.; Kaizuka, M.; Tamura, N.; Tsunoda, S.; Fujita, Y.; Kanazawa, T. 1995: TGF-beta upregulates interleukin 6 production by rat glomerular epithelial cells in vitro. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 10(9): 1592-1597
Oft, M.; Peli, J.; Rudaz, C.; Schwarz, H.; Beug, H.; Reichmann, E. 1996: TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes and Development 10(19): 2462-2477
Vawter, M.P.; Dillon-Carter, O.; Tourtellotte, W.W.; Carvey, P.; Freed, W.J. 1996: TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Experimental Neurology 142(2): 313-322
Soriano, J.V.; Orci, L.; Montesano, R. 1996: TGF-beta1 induces morphogenesis of branching cords by cloned mammary epithelial cells at subpicomolar concentrations. Biochemical and Biophysical Research Communications 220(3): 879-885
Hardman, P.; Landels, E.; Woolf, A.S.; Spooner, B.S. 1994: TGF-beta-1 inhibits growth and branching morphogenesis in embryonic mouse submandibular and sublingual glands in vitro. Development Growth and Differentiation 36(6): 567-577
Cui, W.; Fowlis, D.J.; Bryson, S.; Duffie, E.; Ireland, H.; Balmain, A.; Akhurst, R.J. 1996: TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86(4): 531-542
Bissonnette, E.Y.; Enciso, J.A.; Befus, A.D. 1997: TGF-beta1 inhibits the release of histamine and tumor necrosis factor-alpha from mast cells through an autocrine pathway. American Journal of Respiratory Cell and Molecular Biology 16(3): 275-282
Scorziello, A.; Florio, T.; Bajetto, A.; Thellung, S.; Schettini, G. 1997: TGF-beta1 prevents gp120-induced impairment of Ca2+ homeostasis and rescues cortical neurons from apoptotic death. Journal of Neuroscience Research 49(5): 600-607
Blanchette, F.; Day, R.; Dong, W.; Laprise, M.H.; Dubois, C.M. 1997: TGFbeta1 regulates gene expression of its own converting enzyme furin. Journal of Clinical Investigation 99(8): 1974-1983
Hung, L.M.; Tsai, C.H.; Chen, J.K. 1997: TGF-beta1 selectively suppresses PDGF receptor signaling pathways in MG-63 human osteosarcoma cell. Life Sciences 61(7): 685-693
Islam, K.N.; Kayanoki, Y.; Kaneto, H.; Suzuki, K.; Asahi, M.; Fujii, J.; Taniguchi, N. 1997: TGF-beta1 triggers oxidative modifications and enhances apoptosis in HIT cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase. Free Radical Biology and Medicine 22(6): 1007-1017
Schoecklmann, H.O.; Rupprecht, H.D.; Zauner, I.; Sterzel, R.B. 1997: TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation. Kidney International 51(4): 1228-1236
Sanford, L.P.; Ormsby, I.; Gittenberger-de Groot, A.C.; Sariola, H.; Friedman, R.; Boivin, G.P.; Cardell, E.L.; Doetschman, T. 1997: TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124(13): 2659-2670
Wang, X.; Jin, Q.; Xu, J.; Shen, W.; Wang, J.; Post, M. 1997: TGF-beta 3 inhibits the increased gene expressions of pulmonary surfactant proteins induced by dexamethasone in fetal rat lung in vitro. Chinese Medical Journal 110(8): 590-593
Murata, H.; Zhou, L.; Ochoa, S.; Hasan, A.; Badiavas, E.; Falanga, V. 1997: TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. Journal of Investigative Dermatology 108(3): 258-262
de Luca, A.; Weller, M.; Fontana, A. 1996: TGF-beta-induced apoptosis of cerebellar granule neurons is prevented by depolarization. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(13): 4174-4185
Jurgensmeier, J.; Hofler, P.; Bauer, G. 1994: Tgf-Beta-induced apoptosis of transformed fibroblasts by normal fibroblasts - independence of cell-to-cell contact and dependence on reactive oxygen species. International Journal of Oncology 5(3): 525-531
Takaishi, T.; Matsui, T.; Tsukamoto, T.; Ito, M.; Taniguchi, T.; Fukase, M.; Chihara, K. 1994: TGF-beta-induced macrophage colony-stimulating factor gene expression in various mesenchymal cell lines. American Journal of Physiology 267(1 Pt 1): C25-C31
Gressner, A.M.; Lahme, B.; Mannherz, H.G.; Polzar, B. 1997: TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. Journal of Hepatology 26(5): 1079-1092
Stockwell, B.R.; Schreiber, S.L. 1998: TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins. Chemistry and Biology 5(7): 385-395
Khalsa, O.; Yoon, J.W.; Torres-Schumann, S.; Wharton, K.A. 1998: TGF-beta/BMP superfamily members, Gbb-60A and Dpp, cooperate to provide pattern information and establish cell identity in the Drosophila wing. Development 125(14): 2723-2734
King, C.; Davies, J.; Mueller, R.; Lee, M.S.; Krahl, T.; Yeung, B.; O'Connor, E.; Sarvetnick, N. 1998: TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 8(5): 601-613
Johnson, D.W.; Saunders, H.J.; Brew, B.K.; Poronnik, P.; Cook, D.I.; Field, M.J.; Pollock, C.A. 1998: TGF-beta 1 dissociates human proximal tubule cell growth and Na(+)-H+ exchange activity. Kidney International 53(6): 1601-1607
D'Souza, R.N.; Cavender, A.; Dickinson, D.; Roberts, A.; Letterio, J. 1998: TGF-beta1 is essential for the homeostasis of the dentin-pulp complex. European Journal of Oral Sciences 106(Suppl 1): 185-191
Lindenmuth, D.; van Wijnen, A.J.; Penman, S.; Stein, J.L.; Stein, G.S.; Lian, J.B. 1998: TGF-beta1 modifications in nuclear matrix proteins of osteoblasts during differentiation. Journal of Cellular Biochemistry 69(3): 291-303
Nishimura, S.; Hirakawa-Chung, K.Y.; Yashiro, M.; Inoue, T.; Matsuoka, T.; Fujihara, T.; Murahashi, K.; Sawada, T.; Nakata, B.; Jikihara, I.; Takagi, H.; Sowa, M. 1998: TGF-beta1 produced by gastric cancer cells affects mesothelial cell morphology in peritoneal dissemination. International Journal of Oncology 12(4): 847-851
Carrillo, C.; Cafferata, E.G.; Genovese, J.; O'Reilly, M.; Roberts, A.B.; Santa-Coloma, T.A. 1998: TGF-beta1 up-regulates the mRNA for the Na+/Ca2+ exchanger in neonatal rat cardiac myocytes. Cellular and Molecular Biology 44(3): 543-551
Hu, D.N.; McCormick, S.A.; Lin, A.Y.; Lin, J.Y. 1998: TGF-beta2 inhibits growth of uveal melanocytes at physiological concentrations. Experimental Eye Research 67(2): 143-150
Zerath, E.; Holy, X.; Mouillon, J.M.; Farbos, B.; Machwate, M.; Andre, C.; Renault, S.; Marie, P.J. 1997: TGF-beta2 prevents the impaired chondrocyte proliferation induced by unloading in growth plates of young rats. Life Sciences 61(24): 2397-2406
Saltis, J. 1996: TGF-beta: receptors and cell cycle arrest. Molecular and Cellular Endocrinology 116(2): 227-232
Fautsch, M.P.; Vrabel, A.; Subramaniam, M.; Hefferen, T.E.; Spelsberg, T.C.; Wieben, E.D. 1998: TGFbeta-inducible early gene (TIEG) also codes for early growth response alpha (EGRalpha): evidence of multiple transcripts from alternate promoters. Genomics 51(3): 408-416
Cao, H.; Widlund, H.R.; Simonsson, T.; Kubista, M. 1998: TGGA repeats impair nucleosome formation. Journal of Molecular Biology 281(2): 253-260
Hinney, A.; Dürr, C.; Luckenbach, C.; Ritter, H. 1994: TGGE and HIEF: a comparison of two methods in the detection of carriers of the Z mutation in the alpha-1-antitrypsin gene. Human Genetics 93(5): 571-574
Bos, K.; Wraight, C.; Stanley, K.K. 1993: TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain. EMBO Journal 12(5): 2219-2228
Rajasekaran, A.K.; Humphrey, J.S.; Wagner, M.; Miesenböck, G.; Le Bivic, A.; Bonifacino, J.S.; Rodriguez-Boulan, E. 1994: TGN38 recycles basolaterally in polarized Madin-Darby canine kidney cells. Molecular Biology of the Cell 5(10): 1093-1103
Girotti, M.; Banting, G. 1996: TGN38-green fluorescent protein hybrid proteins expressed in stably transfected eukaryotic cells provide a tool for the real-time, in vivo study of membrane traffic pathways and suggest a possible role for ratTGN38. Journal of Cell Science 109: 2915-2926
Reaves, B.; Horn, M.; Banting, G. 1993: TGN38/41 recycles between the cell surface and the TGN: brefeldin a affects its rate of return to the TGN. Molecular Biology of the Cell 4(1): 93-105
Ramirez, M.I.; Rishi, A.K.; Cao, Y.X.; Williams, M.C. 1997: TGT3, thyroid transcription factor I, and Sp1 elements regulate transcriptional activity of the 1.3-kilobase pair promoter of T1alpha, a lung alveolar type I cell gene. Journal of Biological Chemistry 272(42): 26285-26294
Hantraye, P.; Guibert, B.; Biguet, N.F.; Lavergne, A.; Leviel, V. 1994: TH mRNA over-expression in rats with chronic excitotoxic striatal lesions. Neuroreport 5(18): 2621-2624
Chopra, U.; Vohra, H.; Chhibber, S.; Ganguly, N.K.; Sharma, S. 1997: TH1 pattern of cytokine secretion by splenic cells from pyelonephritic mice after in-vitro stimulation with hsp-65 of Escherichia coli. Journal of Medical Microbiology 46(2): 139-144
Barcellini, W.; Rizzardi, G.P.; Borghi, M.O.; Fain, C.; Lazzarin, A.; Meroni, P.L. 1994: TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. Aids 8(6): 757-762
Romagnani, S. 1996: TH1 and TH2 in human diseases. Clinical Immunology and Immunopathology 80(3 Part 1): 225-235
Ansari, A.A.; Mayne, A.; Hunt, D.; Sundstrom, J.B.; Villinger, F. 1994: TH1/TH2 subset analysis. I. Establishment of criteria for subset identification in PBMC samples from nonhuman primates. Journal of Medical Primatology 23(2-3): 102-107
Saoudi, A.; Kuhn, J.; Huygen, K.; de Kozak, Y.; Velu, T.; Goldman, M.; Druet, P.; Bellon, B. 1993: TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. European Journal of Immunology 23(12): 3096-3103
Riekkinen, P.; Pääkkönen, A.; Karhu, J.; Partanen, J.; Soininen, H.; Laakso, M.; Riekkine, P. 1997: THA disrupts mismatch negativity in Alzheimer disease. Psychopharmacology 133(2): 203-206
Sugimura, T.; Tohkura, A. 1998: THA revision with extensively porous-coated stems. 32 hips followed 2-6.5 years. Acta Orthopaedica Scandinavica 69(1): 11-13
Hara, T.; Yamamoto, T.; Adachi, M.; Shirato, S. 1993: THC-YAG laser sclerostomy ab externo in monkey eyes. Nippon Ganka Gakkai Zasshi 97(7): 786-791
Parker, L.A.; Gillies, T. 1995: THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behavioral Neuroscience 109(1): 71-78
Wang, T.H.; Hung, P.T.; Ho, T.C. 1992: THC:YAG laser sclerostomy with mitomycin subconjunctival injection in rabbits. Journal of Ocular Pharmacology 8(4): 325-332
Rehbock, J.; Chondromatidou, A.; Buchinger, P.; Hermann, A. 1996: The B2 receptor on cultured human decidua cells: release of arachidonic acid by bradykinin. Immunopharmacology 33(1-3): 164-166
Müller, R.; Sergl, M.; Nauerth, U.; Schoppe, D.; Pommerening, K.; Dittrich, H.M. 1997: THEMPO: A knowledge-based system for therapy planning in pediatric oncology. Computers in Biology and Medicine 27(3): 177-200
Cabidoche, Y.-Marie; Ozier-Lafontaine, H. 1995: THERESA: I. Matric water content measurements through thickness variations in vertisols. Agricultural Water Management 28(2): 133-147
Labella, R.; Braden, M.; Clarke, R.L.; Davy, K.W. 1996: THFMA in dental monomer systems. Biomaterials 17(4): 431-436
Golfinopoulos, S.K.; Kostopoulou, M.N.; Lekkas, T.D. 1996: THM formation in the high-bromide water supply of Athens. Journal of Environmental Science and Health Part A Environmental Science and Engineering and Toxic and Hazardous Substance Control 31(1): 67-81
Romano, G.; Mura, I.; Azara, A.; Castiglia, P.; Piana, A.; Picci, V.; Deidda, A.; Ciappeddu, P.L. 1996: THM levels and the use of ozone in the disinfection of water. Igiene Moderna 105(2): 139-161
El-Dib, M., A.; Ali, R., K. 1995: THMs formation during chlorination of raw Nile River water. Water Research 29(1): 375-378
Papadopoulou, M.V.; Ji, M.; Bloomer, W.D. 1996: THNLA-1 as radio/chemosensitiser of EMT-6 tumours in mice. British Journal of Cancer. Suppl 27: S267-S270
Papadopoulou, M.V.; Ji, M.; Bloomer, W.D. 1996: THNLA-1: a DNA-targeted bioreductive agent as chemosensitizer in vitro and in vivo. In Vivo 10(1): 49-57
L.W.i Fan, Q.H.N.an; Cheng Ning Hai 1996: THP-adriamycin incorporated combination chemotherapy in treatment of ovarian carcinoma. Zhongguo Zhongliu Linchuang 23(9): 678-680
Bryson, J.S.; Jennings, C.D.; Caywood, B.E.; Kaplan, A.M. 1993: Thy1+ bone marrow cells regulate the induction of murine syngeneic graft-versus-host disease. Transplantation 56(4): 941-945
Jury, M.R.; Levey, K. 1993: THe Eastern Cape drought. Water S A 19(2): 133-137
Wittenhorst, B.; Vree, M.L.; Ten Ham, P.B.; Velema, J.P. 1998: The National Leprosy Control Programme of Zimbabwe a data analysis, 1983-1992. Leprosy Review 69(1): 46-56
Brawner, M.E.; Mattern, S.G.; Babcock, M.J.; Westpheling, J. 1997: The Streptomyces galP1 promoter has a novel RNA polymerase recognition sequence and is transcribed by a new form of RNA polymerase in vitro. Journal of Bacteriology 179(10): 3222-3231
Plaisier, P.W.; van der Hul, R.L.; Nijs, H.G.; den Toom, R.; Terpstra, O.T.; Bruining, H.A. 1994: The course of biliary and gastrointestinal symptoms after treatment of uncomplicated symptomatic gallstones: results of a randomized study comparing extracorporeal shock wave lithotripsy with conventional cholecystectomy. American Journal of Gastroenterology 89(5): 739-744
Stinnett, E.A.; Childers, N.K.; Wright, J.T.; Rodu, B.K.; Bradley, E.L. 1992: The detection of oral Candida in pediatric leukemia patients. Pediatric Dentistry 14(4): 236-239
Bluehdorn, I. 1998: THe impact of potential disturbances on the behaviour of lapwings Vanellus vanellus during incubation and chick rearing. Vogelwelt 119(2): 105-113
Machado, H.B.; Yates, M.G.; Funayama, S.; Rigo, L.U.; Steffens, M.B.; Souza, E.M.; Pedrosa, F.O. 1995: The ntrBC genes of Azospirillum brasilense are part of a nifR3-like-ntrB-ntrC operon and are negatively regulated. Canadian Journal of Microbiology 41(8): 674-684
Ritsma, W. 1994: The relation between physiological tremor and the 13-Hz oscillations of the arm muscles. Biomedizinische Technik. Biomedical Engineering 39(6): 144-148
Niederkorn, K.; Schmidauer, C. 1996: THe significance of neurosonographic methods in the acute treatment and prevention of stroke. Intensiv- und Notfallbehandlung 21(1): 11-13
D.C.en, W.M.; Janssen, C.R. 1998: THe use of biomarkers in Daphnia magna toxicity testing. Hydrobiologia 367: 199-209
Gamea, A.; Fathi, M.; el-Guindy, A. 1994: The use of the rigid endoscope in trans-sphenoidal pituitary surgery. Journal of Laryngology and Otology 108(1): 19-22
Wan, T.S.; Chan, L.C.; Ngan, H.Y.; Tsao, S.W. 1997: T(High) frequency of telomeric associations in human ovarian surface epithelial cells transformed by human papilloma viral oncogenes. Cancer Genetics and Cytogenetics 95(2): 166-172
Nagamachi, S.; Hoshi, H.; Ohnishi, T.; Jinnouchi, S.; Flores, L.G.; Futami, S.; Watanabe, K.; Tsuboi, Y.; Miyanaga, S.; Morimitsu, T. 1996: Tl-201 SPECT in Kimura's disease involving the parotid glands and cervical nodes. Clinical Nuclear Medicine 21(2): 125-128
Arora, G.D.; Reeves, W.C.; Movahed, A. 1994: Tl-201 liver uptake for assessment of jeopardized myocardium during dipyridamole stress testing. Clinical Nuclear Medicine 19(7): 583-589
Bernard, E.J.; Nicholls, W.; Howman-Giles, R.; Kan, A.; Stevens, M. 1997: Tl-201 positive, Ga-67 negative hepatoblastoma: a case report of a 12-year-old boy. Clinical Nuclear Medicine 22(12): 835-837
Felgar, R.E.; Macon, W.R.; Kinney, M.C.; Roberts, S.; Pasha, T.; Salhany, K.E. 1997: TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. American Journal of Pathology 150(6): 1893-1900
Patan, S. 1998: TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvascular Research 56(1): 1-21
Schnapp, G.; Schnapp, A.; Rosenbauer, H.; Grummt, I. 1994: TIF-IC, a factor involved in both transcription initiation and elongation of RNA polymerase I. EMBO Journal 13(17): 4028-4035
Le Douarin, B.; You, J.; Nielsen, A.L.; Chambon, P.; Losson, R. 1998: TIF1alpha: a possible link between KRAB zinc finger proteins and nuclear receptors. Journal of Steroid Biochemistry and Molecular Biology 65(1-6): 43-50
Voegel, J.J.; Heine, M.J.; Zechel, C.; Chambon, P.; Gronemeyer, H. 1996: TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO Journal 15(14): 3667-3675
Goyer, C.; Altmann, M.; Lee, H.S.; Blanc, A.; Deshmukh, M.; Woolford, J.L.; Trachsel, H.; Sonenberg, N. 1993: TIF4631 and TIF4632: two yeast genes encoding the high-molecular-weight subunits of the cap-binding protein complex (eukaryotic initiation factor 4F) contain an RNA recognition motif-like sequence and carry out an essential function. Molecular and Cellular Biology 13(8): 4860-4874
Antman, E., M.; Investigators, T.-In-Myocardial-Infarction-11b-Trial 1998: TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: A double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. American Heart Journal 135(6 Part 3): S353-S360
Gibson, C.M.; Cannon, C.P.; Daley, W.L.; Dodge, J.T.; Alexander, B.; Marble, S.J.; McCabe, C.H.; Raymond, L.; Fortin, T.; Poole, W.K.; Braunwald, E. 1996: TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93(5): 879-888
Barbagelata, N.A.; Granger, C.B.; Oqueli, E.; Suárez, L.D.; Borruel, M.; Topol, E.J.; Califf, R.M. 1997: TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: A pooled analysis. American Heart Journal 133(3): 273-282
Stringer, K.A. 1998: TIMI grade flow, mortality, and the GUSTO-III trial. Pharmacotherapy 18(4): 699-705
Anderson, J.L.; Karagounis, L.A.; Becker, L.C.; Sorensen, S.G.; Menlove, R.L. 1993: TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Circulation 87(6): 1829-1839
Roeb, E.; Purucker, E.; Breuer, B.; Nguyen, H.; Heinrich, P.C.; Rose-John, S.; Matern, S. 1997: TIMP expression in toxic and cholestatic liver injury in rat. Journal of Hepatology 27(3): 535-544
Arumugam, S.; Hemme, C.L.; Yoshida, N.; Suzuki, K.; Nagase, H.; Berjanskii, M.; Wu, B.; Van Doren, S.R. 1998: TIMP-1 contact sites and perturbations of stromelysin 1 mapped by NMR and a paramagnetic surface probe. Biochemistry 37(27): 9650-9657
Nemeth, J.A.; Rafe, A.; Steiner, M.; Goolsby, C.L. 1996: TIMP-2 growth-stimulatory activity: a concentration- and cell type-specific response in the presence of insulin. Experimental Cell Research 224(1): 110-115
Valente, P.; Fassina, G.; Melchiori, A.; Masiello, L.; Cilli, M.; Vacca, A.; Onisto, M.; Santi, L.; Stetler-Stevenson, W.G.; Albini, A. 1998: TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. International Journal of Cancer 75(2): 246-253
Kinoshita, T.; Sato, H.; Okada, A.; Ohuchi, E.; Imai, K.; Okada, Y.; Seiki, M. 1998: TIMP-2 promotes activation of progelatinase a by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. Journal of Biological Chemistry 273(26): 16098-16103
Ruiz, A.; Brett, P.; Bok, D. 1996: TIMP-3 is expressed in the human retinal pigment epithelium. Biochemical and Biophysical Research Communications 226(2): 467-474
Sun, Y.nfu; Brown, Gilbert, M.; Moyer, Bruce, A. 1995: TIO-2 mediated photooxidation of trichloroethylene and toluene dissolved in fluorocarbon solvents. Chemosphere 31(6): 3575-3584
Díaz, E.; Pfeffer, S.R. 1998: TIP47: A cargo selection device for mannose 6-phosphate receptor trafficking. Cell 93(3): 433-443
Makino, Y.; Mimori, T.; Koike, C.; Kanemaki, M.; Kurokawa, Y.; Inoue, S.; Kishimoto, T.; Tamura, T. 1998: TIP49, homologous to the bacterial DNA helicase RuvB, acts as an autoantigen in human. Biochemical and Biophysical Research Communications 245(3): 819-823
Tanra, A.J.; Kagaya, A.; Okamoto, Y.; Muraoka, M.; Motohashi, N.; Yamawaki, S. 1995: TJS-010, a new prescription of oriental medicine, antagonizes tetrabenazine-induced suppression of spontaneous locomotor activity in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 19(5): 963-971
Kagaya, A.; Tanra, A.J.; Shinno, H.; Kugaya, A.; Muraoka, M.; Oyamada, T.; Uchitomi, Y.; Yamawaki, S. 1996: TJS-010, a new prescription of oriental medicine, enhances 8-OH-DPAT-induced effects in rats. Journal of Neural Transmission 103(1-2): 69-75
Schaaff-Gerstenschläger, I.; Mannhaupt, G.; Vetter, I.; Zimmermann, F.K.; Feldmann, H. 1993: TKL2, a second transketolase gene of Saccharomyces cerevisiae. Cloning, sequence and deletion analysis of the gene. European Journal of Biochemistry 217(1): 487-492
Asada, T.; Kuriyama, R.; Shibaoka, H. 1997: TKRP125, a kinesin-related protein involved in the centrosome-independent organization of the cytokinetic apparatus in tobacco BY-2 cells. Journal of Cell Science 110: 179-189
Morita, A.; Takahashi, T.; Stockert, E.; Nakayama, E.; Tsuji, T.; Matsudaira, Y.; Old, L.J.; Obata, Y. 1994: TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells. Journal of Experimental Medicine 179(3): 777-784
Brailoiu, E.; Huhurez, G.; Slatineanu, S.; Filipeanu, C.M.; Costuleanu, M.; Branisteanu, D.D. 1995: TLC characterization of liposomes containing D-myo-inositol derivatives. Biomedical Chromatography: Bmc 9(4): 175-178
Kowalska, T.; Sajewicz, M.; Nishikawa, S.; Kus, P.; Kashimura, N.; Kolodziejczyk, M.; Inoue, T. 1998: TLC and HPLC separations of selected photosensitive E-Z isomers of pyrazole, pyrimidine, and purine derivatives with potential cytokinin activity. Journal of Planar Chromatography - Modern TLC 11(3): 205-210
Taki, T.; Ishikawa, D. 1997: TLC blotting: application to microscale analysis of lipids and as a new approach to lipid-protein interaction. Analytical Biochemistry 251(2): 135-143
Brailoiu, E.; Beschea, C.; Brailoiu, C.; Costuleanu, A.; Filipeanu, C.M.; Costuleanu, M.; Fallgren, B.; Branisteanu, D.D. 1996: TLC characterization of small unilamellar liposomes containing D-myo-inositol derivatives. Biomedical Chromatography: Bmc 10(5): 233-236
Martin, P.; Morden, W.; Wall, P.; Wilson, I. 1992: TLC combined with tandem mass spectrometry: Application to the analysis of antipyrine and its metabolites in extracts of human urine. Journal of Planar Chromatography - Modern TLC 5(4): 255-258
Zitko, V. 1994: TLC detection of brominated flame retardants in styrofoam. Chemosphere 28(6): 1211-1215
L.Hui Lin 1997: TLC determination of mitoxantrone hydrochloride. Zhongguo Yiyao Gongye Zazhi 28(4): 177-178
Liu Lian 1996: TLC determination of nosiheptide. Zhongguo Yiyao Gongye Zazhi 27(8): 353-355
Gao, D.Min, Wang, A.Min 1997: TLC examination of related substances in fluoxetine hydrochloride. Zhongguo Yiyao Gongye Zazhi 28(4): 175-177
Yan, Y.zhen; Lin, Qiaoling; Xie, Peishan 1993: TLC fingerprint of rhizomata of Coptis spp. China Journal of Chinese Materia Medica 18(6): 329-332, 380
Zheng, H.; Zhu, Y.; Yong, H. 1995: TLC identification and content of diosgenin in Paris chinensis tincture. Acta Academiae Medicinae Shanghai 22(1): 65-66
Cardinali, S.; Szulin, E.; Milani, F. 1995: TLC of mycolic acids for the identification of Tsukamurella and related organisms. Actinomycetes 6(3): 85-87
Yan, Y.; Li, D.; Wu, G. 1995: TLC scanning determination of baicalin content in niuhuang qingxin pills. Zhongguo Zhong Yao Za Zhi 20(1): 33-34; 62
Baranowska, I.; Kozłowska, M. 1995: TLC separation and derivative spectrophotometry of some amino acids. Talanta 42(10): 1553-1557
Amarowicz, R.; Karamac, M.; Rudnicka, B.; Ciska, E. 1995: TLC separation of glucopyranosyl sinapate and other phenolic compounds from rapeseed. Fett Wissenschaft Technologie 97(9): 330-333
Bhushan, R.; Kaur, S. 1997: TLC separation of some common sugars on silica gel plates impregnated with transition metal ions. Biomedical Chromatography: Bmc 11(1): 59-60
Gupta, V.K.; Ali, I.; Khurana, U.; Dhagarra, N. 1995: TLC separation of transition metal ions and their quantitative estimation by atomic absorption spectroscopy. Journal of Liquid Chromatography 18(8): 1671-1681
Bhushan, R.; Joshi, S. 1994: TLC studies on certain aminoglycoside antibiotics. Biomedical Chromatography: Bmc 8(6): 315-316
Klebovich, I.; Szunyog, J.; Hazai, I. 1997: TLC-DAR for the analysis of biological samples. A newly developed rapid tool for studying drug metabolism. Journal of Planar Chromatography - Modern TLC 10(6): 399-405
Chai, W.; Rosankiewicz, J.R.; Lawson, A.M. 1995: TLC-LSIMS of neoglycolipids of glycosaminoglycan disaccharides and of oxymercuration cleavage products of heparin fragments that contain unsaturated uronic acid. Carbohydrate Research 269(1): 111-124
Garg, S.N.; Gupta, M.M.; Kumar, S. 1997: TLC-densitometry: Quantitative determination of betanin in beet root extract. Journal of Medicinal and Aromatic Plant Sciences 19(2): 410-411
Zhang, H.; Zhang, X.Z.; Luo, S.D.; Yang, P. 1997: TLC-scanning determination of diclofenac sodium gel. Zhongguo Yiyao Gongye Zazhi 28(12): 552-554
L.Ping, Lai Bing Sen 1996: TLC-scanning determination of phosphatidylethanolamine in yolk phospholipid. Zhongguo Yiyao Gongye Zazhi 27(5): 222-224
Rochholz, G.; Mayr, A.; Schuetz, H. 1993: TLC-screening of important pharmaceutical substances using fluorescence detection. Fresenius' Journal of Analytical Chemistry 346(6-9): 819-827
Chau, F.T.; Chan, T.P.; Wang, J. 1998: TLCQA: quantitative study of thin-layer chromatography. Bioinformatics 14(6): 540-541
Ertl, A.; Hartl, R.F.; Zehetmayer, M.; Kitz, K.; Griffitt, W. 1996: TLD array for precise dose measurements in stereotactic radiation techniques. Physics in Medicine and Biology 41(12): 2679-2686
Kron, T.; Butson, M.; Hunt, F.; Denham, J. 1996: TLD extrapolation for skin dose determination in vivo. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 41(2): 119-123
Gentry, J.R.; Dewerd, L.A. 1996: TLD measurements of in vivo mammographic exposures and the calculated mean glandular dose across the United States. Medical Physics 23(6): 899-903
Izewska, J.; Gajewski, R.; Gwiazdowska, B.; Kania, M.; Rostkowska, J. 1995: TLD postal dose intercomparison for megavoltage units in Poland. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 36(2): 143-152
Kirov, A.s.; Williamson, J.F.; Meigooni, A.S.; Zhu, Y. 1995: TLD, diode and Monte Carlo dosimetry of an 192Ir source for high dose-rate brachytherapy. Physics in Medicine and Biology 40(12): 2015-2036
Dehni, G.; Liu, Y.; Husain, J.; Stifani, S. 1995: TLE expression correlates with mouse embryonic segmentation, neurogenesis, and epithelial determination. Mechanisms of Development 53(3): 369-381
Nakayama, J.; Saito, M.; Nakamura, H.; Matsuura, A.; Ishikawa, F. 1997: TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88(6): 875-884
Zinszner, H.; Sok, J.; Immanuel, D.; Yin, Y.; Ron, D. 1997: TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. Journal of Cell Science 110: 1741-1750
Powers, C.A.; Mathur, M.; Raaka, B.M.; Ron, D.; Samuels, H.H. 1998: TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors. Molecular Endocrinology 12(1): 4-18
Perrotti, D.; Bonatti, S.; Trotta, R.; Martinez, R.; Skorski, T.; Salomoni, P.; Grassilli, E.; Lozzo, R.V.; Cooper, D.R.; Calabretta, B. 1998: TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO Journal 17(15): 4442-4455
Holmer, I. 1993: TLV in cold environments. Journal of Thermal Biology 18(5-6): 643-646
Sherrington, P.D.; Scott, J.L.; Jin, B.; Simmons, D.; Dorahy, D.J.; Lloyd, J.; Brien, J.H.; Aebersold, R.H.; Adamson, J.; Zuzel, M.; Burns, G.F. 1997: TLiSA1 (PTA1) activation antigen implicated in T cell differentiation and platelet activation is a member of the immunoglobulin superfamily exhibiting distinctive regulation of expression. Journal of Biological Chemistry 272(35): 21735-21744
Denesvre, C.; Carrington, C.; Corbin, A.; Takeuchi, Y.; Cosset, F.L.; Schulz, T.; Sitbon, M.; Sonigo, P. 1996: TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. Journal of Virology 70(7): 4380-4386
Hamada, S.; Nishikawa, T.; Yokoi, N.; Serikawa, T. 1997: TM rats: a model for platelet storage pool deficiency. Experimental Animals 46(3): 235-239
Méjean, V.; Iobbi-Nivol, C.; Lepelletier, M.; Giordano, G.; Chippaux, M.; Pascal, M.C. 1994: TMAO anaerobic respiration in Escherichia coli: Involvement of the tor operon. Molecular Microbiology 11(6): 1169-1179
Oda, A.; Druker, B.J.; Ariyoshi, H.; Smith, M.; Salzman, E.W. 1995: TMB-8 and dibucaine induce tyrosine phosphorylation and dephosphorylation of a common set of proteins in platelets. American Journal of Physiology 269(1 Part 1): C118-C125
Ballerini, P.; Ciccarelli, R.; Di Iorio, P.; Giuliani, P.; Francano, D.; Fanò, G.; Caciagli, F. 1993: TMB-8 and thapsigargin modulate purine release from dissociated primary cultures of rat brain astrocytes. Research Communications in Chemical Pathology and Pharmacology 82(2): 167-174
Kohno, J.; Nishio, M.; Kawano, K.; Nakanishi, N.; Suzuki, S.; Uchida, T.; Komatsubara, S. 1996: TMC-1 A, B, C and D, new antibiotics of the manumycin group produced by Streptomyces sp. Taxonomy, production, isolation, physico-chemical properties, structure elucidation and biological properties. Journal of Antibiotics 49(12): 1212-1220
Asai, Y.; Nonaka, N.; Nishio, M.; Okamura, K.; Date, T.; Sugita, T.; Ohnuki, T.; Komatsubara, S. 1997: TMC-2A, -2B and -2C, new dipeptidyl peptidase IV inhibitors produced by Aspergillus oryzae A374. II. Isolation and structure determination. Journal of Antibiotics 50(8): 653-658
Nonaka, N.; Asai, Y.; Nishio, M.; Takahashi, K.; Okuda, T.; Tanaka, S.; Sugita, T.; Ohnuki, T.; Komatsubara, S. 1997: TMC-2A, -2B and -2C, novel dipeptidyl peptidase IV inhibitors produced by Aspergillus oryzae A374. I. Taxonomy of producing strain, fermentation, and biochemical properties. Journal of Antibiotics 50(8): 646-652
Koguchi, Y.; Asai, Y.; Suzuki, S.; Nishio, M.; Yanaka, N.; Omori, K.; Ohnuki, T.; Komatsubara, S. 1998: TMC-49A, a novel transcriptional up-regulator of low density lipoprotein receptor, produced by Streptomyces sp. AS1345. Journal of Antibiotics 51(2): 107-111
Isshiki, K.; Nishio, M.; Sakurai, N.; Uchida, T.; Okuda, T.; Komatsubara, S. 1998: TMC-52A to D, novel cysteine proteinase inhibitors, produced by Gliocladium sp. Journal of Antibiotics 51(7): 629-634
Christensen, L.V.; McKay, D.C. 1996: TMD diagnostic decision-making and probability theory. Part II. Cranio: the Journal of Craniomandibular Practice 14(4): 312-319
Christensen, L.V.; McKay, D.C. 1996: TMD diagnostic decision-making and probability theory. Part I. Cranio: the Journal of Craniomandibular Practice 14(3): 240-248
Kuttila, M.; Niemi, P.M.; Kuttila, S.; Alanen, P.; Le Bell, Y. 1998: TMD treatment need in relation to age, gender, stress, and diagnostic subgroup. Journal of Orofacial Pain 12(1): 67-74
Steed, P.A. 1998: TMD treatment outcomes: a statistical assessment of the effects of psychological variables. Cranio: the Journal of Craniomandibular Practice 16(3): 138-142
Bracco, P.; Deregibus, A.; Piscetta, R.; Giaretta, G.A. 1997: TMJ clicking: a comparison of clinical examination, sonography, and axiography. Cranio: the Journal of Craniomandibular Practice 15(2): 121-126
de Mol van Otterloo, J.J.; Dorenbos, J.; Tuinzing, D.B.; van der Kwast, W.A. 1993: TMJ performance and behaviour in patients more than 6 years after Le Fort I osteotomy. British Journal of Oral and Maxillofacial Surgery 31(2): 83-86
Razis, E.D.; Samonis, G.; Cook, P.; Beer, M.; Mittelman, A.; Lake, D.E.; Feldman, E.J.; Puccio, C.; Ahmed, T. 1994: TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer. Journal of Medicine 25(3-4): 241-250
Sugiyama, Y.; Ishikawa, E.; Odaka, H.; Miki, N.; Tawada, H.; Ikeda, H. 1995: TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters. Atherosclerosis 113(1): 71-78
Nishizawa, M.; Garcia, D.M.; Noguchi, Y.; Komatsu, K.; Hatakeyama, S.; Yamada, H. 1994: TMS triflate induced synthesis of 1,1'-disaccharides from 1-hydroxy sugars. Chemical and Pharmaceutical Bulletin 42(11): 2400-2402
Livne, B.; Faktor, O.; Zeitoune, S.; Edelbaum, O.; Sela, I. 1997: TMV-induced expression of tobacco beta-glucanase promoter activity is mediated by a single, inverted, GCC motif. Plant Science (Shannon) 130(2): 159-169
Campbell, D.A.; Nelson, S.; Madhok, R.; Field, M.; Gallagher, G. 1994: TNF Nco-I RFLP is not an independent risk factor in rheumatoid arthritis. European Journal of Immunogenetics: Official Journal of the British Society for Histocompatibility and Immunogenetics 21(6): 461-467
Volland, S.; Amtmann, E.; Sauer, G. 1994: TNF accelerates the S-phase of the cell cycle in tumor cells. International Journal of Cancer 56(5): 698-705
Elliott, M.J.; Feldmann, M.; Maini, R.N. 1995: TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action. International Journal of Immunopharmacology 17(2): 141-145
Xing, H.; Northrop, J.P.; Grove, J.R.; Kilpatrick, K.E.; Su, J.L.; Ringold, G.M. 1997: TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression. Endocrinology 138(7): 2776-2783
Boccazzi, A.; Erroi, A.; Mantegazza, M.; Bellosta, C.; Ghezzi, P. 1993: TNF and IL-1 in a rabbit model of meningitis. International Journal of Immunopathology and Pharmacology 6(2): 85-91
Börset, M.; Waage, A.; Brekke, O.L.; Helseth, E. 1994: TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line. European Journal of Haematology 53(1): 31-37
Smith, R.E.; Strieter, R.M.; Phan, S.H.; Lukacs, N.; Kunkel, S.L. 1998: TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. Journal of Leukocyte Biology 64(4): 528-536
Hazout, A. 1995: TNF and infection. Contraception Fertilite Sexualite 23(10): 631-634
Totpal, K.; LaPushin, R.; Kohno, T.; Darnay, B.G.; Aggarwal, B.B. 1994: TNF and its receptor antibody agonist differ in mediation of cellular responses. Journal of Immunology 153(5): 2248-2257
Rongieres Bertrand, C.; Menu, E.; Lelaidier, C.; Delage, G.; Chaouat, G.; Frydman, R. 1997: TNF and labour. Contraception Fertilite Sexualite 25(1): 51-57
Maini, R.N.; Elliott, M.; Brennan, F.M.; Williams, R.O.; Feldmann, M. 1997: TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 105(4): 257-263
Denham, W.; Yang, J.; Fink, G.; Denham, D.; Carter, G.; Bowers, V.; Norman, J. 1998: TNF but not IL-1 decreases pancreatic acinar cell survival without affecting exocrine function: a study in the perfused human pancreas. Journal of Surgical Research 74(1): 3-7
Llovera, M.; García-Martínez, C.; Agell, N.; López-Soriano, F.J.; Argilés, J.M. 1997: TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochemical and Biophysical Research Communications 230(2): 238-241
Tang, P.; Hung, M.C.; Klostergaard, J. 1994: TNF cytotoxicity: effects of HER-2/neu expression and inhibitors of ADP-ribosylation. Lymphokine and Cytokine Research 13(2): 117-123
Sakurai, Y.; Zhang, X.J.; Wolfe, R.R. 1996: TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. American Journal of Physiology 270(5 Pt 1): E864-E872
Schraut, W.; Wendelgass, P.; Calzada-Wack, J.C.; Frankenberger, M.; Ziegler-Heitbrock, H.W. 1997: TNF gene expression in monocytes of low and high responder individuals. Cytokine 9(3): 206-211
Santiago-Schwarz, F.; Belilos, E.; Diamond, B.; Carsons, S.E. 1992: TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. Journal of Leukocyte Biology 52(3): 274-281
Higuchi, M.; Aggarwal, B.B. 1994: TNF induces internalization of the p60 receptor and shedding of the p80 receptor. Journal of Immunology 152(7): 3550-3558
Fishman, M.; Costlow, M. 1994: TNF induction of EL4 hyposensitivity to lysis by recombinant (Soluble) and membrane-associated TNFs: TNF binding, internalization, and degradation. Cellular Immunology 154(1): 453-467
Fenner, H. 1995: TNF inhibition, a novel therapeutic perspective in chronic-inflammatory rheumatic diseases?. Zeitschrift fuer Rheumatologie 54(3): 158-164
Brennan, F.M.; Gibbons, D.L.; Cope, A.P.; Katsikis, P.; Maini, R.N.; Feldmann, M. 1995: TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action. Scandinavian Journal of Immunology 42(1): 158-165
Hybertson, B.M.; Jepson, E.K.; Cho, O.J.; Clarke, J.H.; Lee, Y.M.; Repine, J.E. 1997: TNF mediates lung leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally. American Journal of Respiratory and Critical Care Medicine 155(6): 1972-1976
Hajeer, A.H.; Worthington, J.; Davies, E.J.; Hillarby, M.C.; Poulton, K.; Ollier, W.E. 1997: TNF microsatellite a2, b3 and d2 alleles are associated with systemic lupus erythematosus. Tissue Antigens 49(3 Pt 1): 222-227
Polvi, A.; Mäki, M.; Collin, P.; Partanen, J. 1998: TNF microsatellite alleles a2 and b3 are not primarily associated with celiac disease in the Finnish population. Tissue Antigens 51(5): 553-555
Koga, S.; Morris, S.; Ogawa, S.; Liao, H.; Bilezikian, J.P.; Chen, G.; Thompson, W.J.; Ashikaga, T.; Brett, J.; Stern, D.M. 1995: TNF modulates endothelial properties by decreasing cAMP. American Journal of Physiology 268(5 Part 1): C1104-C1113
Hart, P.H.; Grimbaldeston, M.A.; Swift, G.J.; Sedgwick, J.D.; Körner, H.; Finlay-Jones, J.J. 1998: TNF modulates susceptibility to UVB-induced systemic immunomodulation in mice by effects on dermal mast cell prevalence. European Journal of Immunology 28(9): 2893-2901
Chang, S.W. 1994: TNF potentiates PAF-induced pulmonary vasoconstriction in the rat: role of neutrophils and thromboxane A2. Journal of Applied Physiology 77(6): 2817-2826
Castagnoli, C.; Stella, M.; Berthod, C.; Magliacani, G.; Richiardi, P.M. 1993: TNF production and hypertrophic scarring. Cellular Immunology 147(1): 51-63
Kulseng, B.; Skjåk-Braek, G.; Følling, I.; Espevik, T. 1996: TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide. Scandinavian Journal of Immunology 43(3): 335-340
Hafner, M.; Orosz, P.; Krüger, A.; Männel, D.N. 1996: TNF promotes metastasis by impairing natural killer cell activity. International Journal of Cancer 66(3): 388-392
Schwandner, R.; Wiegmann, K.; Bernardo, K.; Kreder, D.; Kronke, M. 1998: TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. Journal of Biological Chemistry 273(10): 5916-5922
Butler, D.M.; Scallon, B.; Meager, A.; Kissonerghis, M.; Corcoran, A.; Chernajovsky, Y.; Feldmann, M.; Ghrayeb, J.; Brennan, F.M. 1994: TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells. Cytokine 6(6): 616-623
Fishman, M.; Larche, M. 1993: TNF receptor involvement in TNF-mediated activities against syngeneic malignant and normal mouse thymocytes. Cellular Immunology 152(2): 510-521
VanArsdale, T.L.; Ware, C.F. 1994: TNF receptor signal transduction. Ligand-dependent stimulation of a serine protein kinase activity associated with (CD120a) TNFR60. Journal of Immunology 153(7): 3043-3050
Grell, M.; Becke, F.M.; Wajant, H.; Männel, D.N.; Scheurich, P. 1998: Tumor necrosis factor (TNF) receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. European Journal of Immunology 28(1): 257-263
Grell, M.; Zimmermann, G.; Hülser, D.; Pfizenmaier, K.; Scheurich, P. 1994: TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. Journal of Immunology 153(5): 1963-1972
Lucas, R.; Lou, J.; Morel, D.R.; Ricou, B.; Suter, P.M.; Grau, G.E. 1997: TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. Journal of Leukocyte Biology 61(5): 551-558
Kozak, W.; Conn, C.A.; Klir, J.J.; Wong, G.H.; Kluger, M.J. 1995: TNF soluble receptor and antiserum against TNF enhance lipopolysaccharide fever in mice. American Journal of Physiology 269(1 Part 2): R23-R29
Haveman, J.; Geerdink, A.G.; Rodermond, H.M. 1998: TNF, IL-1 and IL-6 in circulating blood after total-body and localized irradiation in rats. Oncology Reports 5(3): 679-683
Arntzen, K.J.; Kjøllesdal, A.M.; Halgunset, J.; Vatten, L.; Austgulen, R. 1998: TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. Journal of Perinatal Medicine 26(1): 17-26
Westermarck, J.; Häkkinen, L.; Fiers, W.; Kähäri, V.M. 1995: TNF-R55-specific form of human tumor necrosis factor-alpha induces collagenase gene expression by human skin fibroblasts. Journal of Investigative Dermatology 105(2): 197-202
Lau, K.S.; Nakashima, O.; Aalund, G.R.; Hogarth, L.; Ujiie, K.; Yuen, J.; Star, R.A. 1995: TNF-alpha and IFN-gamma induce expression of nitric oxide synthase in cultured rat medullary interstitial cells. American Journal of Physiology 269(2 Part 2): F212-F217
Leenen, P.J.; Canono, B.P.; Drevets, D.A.; Voerman, J.S.; Campbell, P.A. 1994: TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. Journal of Immunology 153(11): 5141-5147
Barnes, D.A.; Huston, M.; Perez, H.D. 1998: TNF-alpha and IL-1beta cross-desensitization of astrocytes and astrocytoma cell lines. Journal of Neuroimmunology 87(1-2): 17-26
Matuschak, G.M.; Munoz, C.; Epperly, N.A.; Britton, R.S.; Walsh, D.; Schilly, D.R.; Tredway, T.L.; Khan, T.A.; Bacon, B.R.; Lechner, A.J. 1994: TNF-alpha and IL-6 expression in perfused rat liver after intraportal candidemia vs. E. coli or S. aureus bacteremia. American Journal of Physiology 267(2 Pt 2): R446-R454
Nilsson, G.; Carlsson, M.; Jones, I.; Ahlstedt, S.; Matsson, P.; Nilsson, K. 1994: TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812. Immunology 81(1): 73-78
Pailla, K.; Lim, S.K.; De Bandt, J.P.; Aussel, C.; Giboudeau, J.; Troupel, S.; Cynober, L.; Blonde-Cynober, F. 1998: TNF-alpha and IL-6 synergistically inhibit ketogenesis from fatty acids and alpha-ketoisocaproate in isolated rat hepatocytes. Jpen. Journal of Parenteral and Enteral Nutrition 22(5): 286-290
Strickland, I.; Rhodes, L.E.; Flanagan, B.F.; Friedmann, P.S. 1997: TNF-alpha and IL-8 are upregulated in the epidermis of normal human skin after UVB exposure: Correlation with neutrophil accumulation and E-selectin expression. Journal of Investigative Dermatology 108(5): 763-768
Skoff, A.M.; Lisak, R.P.; Bealmear, B.; Benjamins, J.A. 1998: TNF-alpha and TGF-beta act synergistically to kill Schwann cells. Journal of Neuroscience Research 53(6): 747-756
Sagi-Assif, O.; Traister, A.; Katz, B.Z.; Anavi, R.; Eskenasy, M.; Witz, I.P. 1996: TNFalpha and anti-Fas antibodies regulate Ly-6E.1 expression by tumor cells: a possible link between angiogenesis and Ly-6E.1. Immunology Letters 54(2-3): 207-213
Sumida, M.; Isawa, E.; Kobayashi, K.; Inaba, H.; Fujimoto, S. 1996: TNF-alpha and endotoxin serum levels in cancer patients undergoing intraperitoneal hyperthermic perfusion. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 12(5): 607-615
Kronborg, G.; Fomsgaard, A.; Shand, G.H.; Lanng, S.; Hansen, M.B.; Pressler, T.; Hoiby, N. 1992: TNF-alpha and immune complexes in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Immunology and Infectious Diseases 2(3): 171-177
Peraldi, P.; Spiegelman, B. 1998: TNF-alpha and insulin resistance: summary and future prospects. Molecular and Cellular Biochemistry 182(1-2): 169-175
Meng, X.; Ao, L.; Meldrum, D.R.; Cain, B.S.; Shames, B.D.; Selzman, C.H.; Banerjee, A.; Harken, A.H. 1998: TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. American Journal of Physiology 275(2): R502-R508
Perkowski, S.Z.; Sloane, P.J.; Spath, J.A.; Elsasser, T.H.; Fisher, J.K.; Gee, M.H. 1996: TNF-alpha and the pathophysiology of endotoxin-induced acute respiratory failure in sheep. Journal of Applied Physiology 80(2): 564-573
Hershkoviz, R.; Cahalon, L.; Miron, S.; Alon, R.; Sapir, T.; Akiyama, S.K.; Yamada, K.M.; Lider, O. 1994: TNF-alpha associated with fibronectin enhances phorbol myristate acetate- or antigen-mediated integrin-dependent adhesion of CD4+ T cells via protein tyrosine phosphorylation. Journal of Immunology 153(2): 554-565
Mariani, E.; Tarozzi, A.; Meneghetti, A.; Cattini, L.; Facchini, A. 1998: TNF-alpha but not IL-1 and IL-6 modifies the susceptibility of human osteosarcoma cells to NK lysis. International Journal of Oncology 13(2): 349-353
Ferraz, J.G.; Tigley, A.W.; Appleyard, C.B.; Wallace, J.L. 1997: TNF-alpha contributes to the pathogenesis of ethanol-induced gastric damage in cirrhotic rats. American Journal of Physiology 272(4 Pt 1): G809-G814
Amour, A.; Slocombe, P.M.; Webster, A.; Butler, M.; Knight, C.G.; Smith, B.J.; Stephens, P.E.; Shelley, C.; Hutton, M.; Knäuper, V.; Docherty, A.J.; Murphy, G. 1998: TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. Febs Letters 435(1): 39-44
Scagliotti, G.; Gatti, E.; Ferrari, G.; Mutti, L.; Pozzi, E. 1995: Tnp-alpha determination in serum and pleural effusion in patients with lung-cancer. International Journal of Oncology 6(1): 147-151
Müssener, A.; Klareskog, L.; Lorentzen, J.C.; Kleinau, S. 1995: TNF-alpha dominates cytokine mRNA expression in lymphoid tissues of rats developing collagen- and oil-induced arthritis. Scandinavian Journal of Immunology 42(1): 128-134
Beier, K.; Völkl, A.; Fahimi, H.D. 1997: TNF-alpha downregulates the peroxisome proliferator activated receptor-alpha and the mRNAs encoding peroxisomal proteins in rat liver. Febs Letters 412(2): 385-387
Ricard, J.; Pelloux, H.; Pathak, S.; Pipy, B.; Ambroise-Thomas, P. 1996: TNF-alpha enhances Toxoplasma gondii cyst formation in human fibroblasts through the sphingomyelinase pathway. Cellular Signalling 8(6): 439-442
Moore, K.J.; Yeh, K.; Naito, T.; Kelley, V.R. 1996: TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease. Journal of Immunology 157(1): 427-432
Aloe, L.; Fiore, M. 1997: TNF-alpha expressed in the brain of transgenic mice lowers central thyroxine hydroxylase immunoreactivity and alters grooming behavior. Neuroscience Letters 238(1-2): 65-68
Cipollaro de L'Ero, G.; Marcatili, A.; Folgore, A.; Donnarumma, G.; Petrillo, G. 1998: TNF-alpha expression and herpes simplex infection in human monocytes treated with growth hormone, prolactin and insulin. New Microbiologica 21(3): 213-220
Renno, T.; Krakowski, M.; Piccirillo, C.; Lin, J.Y.; Owens, T. 1995: TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. Journal of Immunology 154(2): 944-953
Swain, M.G.; Appleyard, C.B.; Wallace, J.L.; Maric, M. 1997: TNF-alpha facilitates inflammation-induced glucocorticoid secretion in rats with biliary obstruction. Journal of Hepatology 26(2): 361-368
Okamoto, T.; Furuya, M.; Yamakawa, T.; Yamamura, K.; Hino, O. 1996: TNF-alpha gene expression in the liver of the IFN-gamma transgenic mouse with chronic active hepatitis. Biochemical and Biophysical Research Communications 226(3): 762-768
De Blaauw, I.; Eggermont, A.M.; Deutz, N.E.; de Vries, M.; Buurman, W.A.; Von Meyenfeldt, M.F. 1997: TNF-alpha has no direct in vivo metabolic effect on human muscle. International Journal of Cancer 71(2): 148-154
Hales, C.A.; Elsasser, T.H.; Ocampo, P.; Efimova, O. 1997: TNF-alpha in smoke inhalation lung injury. Journal of Applied Physiology 82(5): 1433-1437
Chou, D.H.; Lee, W.; McCulloch, C.A. 1996: TNF-alpha inactivation of collagen receptors: implications for fibroblast function and fibrosis. Journal of Immunology 156(11): 4354-4362
McCarthy, E.T.; Sharma, R.; Sharma, M.; Li, J.Z.; Ge, X.L.; Dileepan, K.N.; Savin, V.J. 1998: TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide. Journal of the American Society of Nephrology: Jasn 9(3): 433-438
Kurokouchi, K.; Kambe, F.; Yasukawa, K.; Izumi, R.; Ishiguro, N.; Iwata, H.; Seo, H. 1998: TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 13(8): 1290-1299
Grassi, F.; Mileo, A.M.; Monaco, L.; Punturieri, A.; Santoni, A.; Eusebi, F. 1994: TNF-alpha increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons. Brain Research 659(1-2): 226-230
Goldblum, S.E.; Ding, X.; Campbell-Washington, J. 1993: TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. American Journal of Physiology 264(4 Pt 1): C894-C905
Porras, A.; Alvarez, A.M.; Valladares, A.; Benito, M. 1997: TNF-alpha induces apoptosis in rat fetal brown adipocytes in primary culture. Febs Letters 416(3): 324-328
Phelps, D.T.; Ferro, T.J.; Higgins, P.J.; Shankar, R.; Parker, D.M.; Johnson, A. 1995: TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. American Journal of Physiology 269(4 Part 1): L551-L559
Kunkel, E.J.; Jung, U.; Ley, K. 1997: TNF-alpha induces selectin-mediated leukocyte rolling in mouse cremaster muscle arterioles. American Journal of Physiology 272(3 Part 2): H1391-H1400
van Kooten, C.; Rensink, I.; Aarden, L.; van Oers, R. 1993: TNF-alpha induces spreading of B-CLL via the CD11c/CD18 molecule. American Journal of Hematology 44(4): 221-228
Grimbacher, B.; Aicher, W.K.; Peter, H.H.; Eibel, H. 1998: TNF-alpha induces the transcription factor Egr-1, pro-inflammatory cytokines and cell proliferation in human skin fibroblasts and synovial lining cells. Rheumatology International 17(5): 185-192
Rafiee, P.; Lee, J.K.; Leung, C.C.; Raffin, T.A. 1995: TNF-alpha induces tyrosine phosphorylation of mitogen-activated protein kinase in adherent human neutrophils. Journal of Immunology 154(9): 4785-4792
Pang, X.P.; Hershman, J.M.; Karsan, A. 1997: TNF-alpha induction of A1 expression in human cancer cells. Oncology Research 9(11-12): 623-627
Park, E.; Kalunta, C.I.; Nguyen, T.T.; Wang, C.L.; Chen, F.S.; Lin, C.K.; Kaptein, J.S.; Lad, P.M. 1996: TNF-alpha inhibits anti-IgM-mediated apoptosis in Ramos cells. Experimental Cell Research 226(1): 1-10
Zhang, S.; Kim, K.H. 1995: TNF-alpha inhibits glucose-induced insulin secretion in a pancreatic beta-cell line (INS-1). Febs Letters 377(2): 237-239
Emala, C.W.; Kuhl, J.; Hungerford, C.L.; Hirshman, C.A. 1997: TNF-alpha inhibits isoproterenol-stimulated adenylyl cyclase activity in cultured airway smooth muscle cells. American Journal of Physiology 272(4 Pt 1): L644-L650
Rogers, J.A.; Berman, J.W. 1994: TNF-alpha inhibits the further development of committed progenitors while stimulating multipotential progenitors in mouse long-term bone marrow cultures. Journal of Immunology 153(10): 4694-4703
Clarke, G.R.; Shirzadeh, H.; Pang, G.; Beagley, K.W.; Burton, R.C.; Smart, Y.C. 1997: TNF-alpha is not the sole mediator of WEHI-164 tumour cell killing in natural cytotoxicity. Cytokine 9(4): 254-262
Shindoh, C.; Hida, W.; Ohkawara, Y.; Yamauchi, K.; Ohno, I.; Takishima, T.; Shirato, K. 1995: TNF-alpha mRNA expression in diaphragm muscle after endotoxin administration. American Journal of Respiratory and Critical Care Medicine 152(5 Part 1): 1690-1696
Ogura, T.; Tatemichi, M.; Esumi, H. 1997: TNF-alpha mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin. Biochemical and Biophysical Research Communications 233(3): 788-791
Lukacs, N.W.; Strieter, R.M.; Chensue, S.W.; Widmer, M.; Kunkel, S.L. 1995: TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. Journal of Immunology 154(10): 5411-5417
Kuncio, G.S.; Tsyganskaya, M.; Zhu, J.; Liu, S.L.; Nagy, L.; Thomazy, V.; Davies, P.J.; Zern, M.A. 1998: TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. American Journal of Physiology 274(2): G240-G245
Fiala, M.; Looney, D.J.; Stins, M.; Way, D.D.; Zhang, L.; Gan, X.; Chiappelli, F.; Schweitzer, E.S.; Shapshak, P.; Weinand, M.; Graves, M.C.; Witte, M.; Kim, K.S. 1997: TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Molecular Medicine 3(8): 553-564
Nagai, H.; Sakurai, T.; Abe, T.; Matsuo, A.; Musoh, K.; Tsunematsu, M.; Inagaki, N. 1996: TNF-alpha participates in an IgE-mediated cutaneous reaction in mast cell deficient, WBB6F1-W/Wv mice. Inflammation Research: Official Journal of the European Histamine Research Society . 45(3): 136-140
Gilmont, R.R.; Dardano, A.; Engle, J.S.; Adamson, B.S.; Welsh, M.J.; Li, T.; Remick, D.G.; Smith, D.J.; Rees, R.S. 1996: TNF-alpha potentiates oxidant and reperfusion-induced endothelial cell injury. Journal of Surgical Research 61(1): 175-182
Ujházy, P.; Maccubbin, D.; Eppolito, C.; Mihich, E.; Ehrke, M.J. 1994: TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells. Lymphokine and Cytokine Research 13(2): 99-106
Nawashiro, H.; Tasaki, K.; Ruetzler, C.A.; Hallenbeck, J.M. 1997: TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 17(5): 483-490
Robinet, E.; Morel, P.; Assossou, O.; Revillard, J.P. 1995: TNF-alpha production as an in vitro assay predictive of cytokine-mediated toxic reactions induced by monoclonal antibodies. Toxicology 100(1-3): 213-223
Finotto, S.; Ohno, I.; Marshall, J.S.; Gauldie, J.; Denburg, J.A.; Dolovich, J.; Clark, D.A.; Jordana, M. 1994: TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). Journal of Immunology 153(5): 2278-2289
Huizinga, T.W.; Westendorp, R.G.; Bollen, E.L.; Keijsers, V.; Brinkman, B.M.; Langermans, J.A.; Breedveld, F.C.; Verweij, C.L.; van de Gaer, L.; Dams, L.; Crusius, J.B.; García-Gonzalez, A.; van Oosten, B.W.; Polman, C.H.; Peña, A.S. 1997: TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. Journal of Neuroimmunology 72(2): 149-153
Klinkert, W.E.; Kojima, K.; Lesslauer, W.; Rinner, W.; Lassmann, H.; Wekerle, H. 1997: TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. Journal of Neuroimmunology 72(2): 163-168
Hashimoto, S.; Gon, Y.; Hayashi, S.; Tomita, Y.; Yodoi, J.; Horie, T. 1997: TNF-alpha regulates GM-CSF-, IL-3- or M-CSF-induced Fc epsilon RII/CD23 gene expression and soluble Fc epsilon RIi release by human monocytes. Scandinavian Journal of Immunology 45(3): 255-260
Sheerin, N.S.; Zhou, W.; Adler, S.; Sacks, S.H. 1997: TNF-alpha regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells. Kidney International 51(3): 703-710
Oshiro, Y.; Morris, D.L. 1997: TNF-alpha release from human peripheral blood mononuclear cells to predict the proinflammatory activity of cytokines and growth factors. Journal of Pharmacological and Toxicological Methods 37(1): 55-59
Horgan, M.J.; Palace, G.P.; Everitt, J.E.; Malik, A.B. 1993: TNF-alpha release in endotoxemia contributes to neutrophil-dependent pulmonary edema. American Journal of Physiology 264(4 Pt 2): H1161-H1165
Petersen, F.; Ludwig, A.; Flad, H.D.; Brandt, E. 1996: TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. Journal of Immunology 156(5): 1954-1962
Gan, H.; Newman, G.; McCarthy, P.L.; Remold, H.G. 1993: TNF-alpha response of human monocyte-derived macrophages to Mycobacterium avium, serovar 4, is of brief duration and protein kinase C dependent. Journal of Immunology 150(7): 2892-2900
Yamasaki, H.; Yamaguchi, Y.; Takino, H.; Matsuo, H.; Matsumoto, K.; Uotani, S.; Akazawa, S.; Yamashita, S.; Nagataki, S. 1996: TNF-alpha stimulates glucose uptake in L6 myoblasts. Diabetes Research and Clinical Practice 32(1-2): 11-18
Klein, J.B.; Scherzer, J.A.; Harding, G.; Jacobs, A.A.; McLeish, K.R. 1995: TNF-alpha stimulates increased plasma membrane guanine nucleotide binding protein activity in polymorphonuclear leukocytes. Journal of Leukocyte Biology 57(3): 500-506
Pai, R.; Bassa, B.; Kirschenbaum, M.A.; Kamanna, V.S. 1996: TNF-alpha stimulates monocyte adhesion to glomerular mesangial cells. The role of intercellular adhesion molecule-1 gene expression and protein kinases. Journal of Immunology 156(7): 2571-2579
Kawakami, Y.; Watanabe, Y.; Yamaguchi, M.; Sakaguchi, H.; Kono, I.; Ueki, A. 1997: TNF-alpha stimulates the biosynthesis of complement C3 and factor B by human umbilical cord vein endothelial cells. Cancer Letters 116(1): 21-26
Battegay, E.J.; Raines, E.W.; Colbert, T.; Ross, R. 1995: TNF-alpha stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. Journal of Immunology 154(11): 6040-6047
Hooper, W.C.; Phillips, D.J.; Evatt, B.L. 1996: TNF-alpha suppresses IL-6 upregulation of protein S in HepG-2 hepatoma cells. Thrombosis Research 81(3): 315-326
Porter, M.H.; Arnold, M.; Langhans, W. 1998: TNF-alpha tolerance blocks LPS-induced hypophagia but LPS tolerance fails to prevent TNF-alpha-induced hypophagia. American Journal of Physiology 274(3): R741-R745
Probert, L.; Akassoglou, K.; Kassiotis, G.; Pasparakis, M.; Alexopoulou, L.; Kollias, G. 1997: TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. Journal of Neuroimmunology 72(2): 137-141
Lan, H.Y.; Yang, N.; Metz, C.; Mu, W.; Song, Q.; Nikolic-Paterson, D.J.; Bacher, M.; Bucala, R.; Atkins, R.C. 1997: TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis. Molecular Medicine 3(2): 136-144
Pekary, A.E.; Berg, L.; Wang, J.; Lee, P.; Dubinett, S.M.; Hershman, J.M. 1995: TNF-alpha, TSH, and aging regulate TGF-beta synthesis and secretion in FRTL-5 rat thyroid cells. American Journal of Physiology 268(3 Pt 2): R808-R815
Benveniste, E.N.; Benos, D.J. 1995: TNF-alpha- and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function. FASEB Journal 9(15): 1577-1584
Di Pietro, R.; Santavenere, E.; Centurione, L.; Stuppia, L.; Centurione, M.A.; Vitale, M.; Rana, R. 1997: TNF-alpha-induced apoptosis in Daudi cells: multiparametric analysis. Cytokine 9(7): 463-470
Fleshner, M.; Silbert, L.; Deak, T.; Goehler, L.E.; Martin, D.; Watkins, L.R.; Maier, S.F. 1997: TNF-alpha-induced corticosterone elevation but not serum protein or corticosteroid binding globulin reduction is vagally mediated. Brain Research Bulletin 44(6): 701-706
Vara, E.; Arias-Díaz, J.; García, C.; Hernández, J.; Balibrea, J.L. 1996: TNF-alpha-induced inhibition of PC synthesis by human type II pneumocytes is sequentially mediated by PGE2 and NO. American Journal of Physiology 271(3 Pt 1): L359-L365
Miles, P.D.; Romeo, O.M.; Higo, K.; Cohen, A.; Rafaat, K.; Olefsky, J.M. 1997: TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46(11): 1678-1683
Curtis, T.M.; Rotundo, R.F.; Vincent, P.A.; McKeown-Longo, P.J.; Saba, T.M. 1998: TNF-alpha-induced matrix Fn disruption and decreased endothelial integrity are independent of Fn proteolysis. American Journal of Physiology 275(1): L126-L138
Riches, D.W.; Chan, E.D.; Winston, B.W. 1996: TNF-alpha-induced regulation and signalling in macrophages. Immunobiology 195(4-5): 477-490
Smart, S.J.; Casale, T.B. 1994: TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent. American Journal of Physiology 266(3 Part 1): L238-L245
Migita, K.; Eguchi, K.; Kawabe, Y.; Ichinose, Y.; Tsukada, T.; Aoyagi, T.; Nakamura, H.; Nagataki, S. 1996: TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 89(4): 553-557
Yu, F.; Itoyama, Y.; Kira, J.; Fujihara, K.; Kobayashi, T.; Kitamoto, T.; Suzumura, A.; Yamamoto, N.; Nakajima, Y.; Goto, I. 1994: TNF-beta produced by human T lymphotropic virus type I-infected cells influences the proliferation of human endothelial cells and fibroblasts. Journal of Immunology 152(12): 5930-5938
Goldstein, L.A.; Strieter, R.M.; Evanoff, H.L.; Kunkel, S.L.; Lukacs, N.W. 1996: TNF-induced IL-8 and MCP-1 production in the eosinophilic cell line, EOL-1. Mediators of Inflammation 5(3): 218-223
Flugy, A.; Borsellino, N.; D'Alessandro, N. 1995: TNF-induced apoptosis in multidrug resistant friend erythroleukemia is not influenced by the P-glycoprotein and glutathione status of the cell line. Oncology Research 7(10-11): 559-564
Bogin, L.; Papa, M.Z.; Polak-Charcon, S.; Degani, H. 1998: TNF-induced modulations of phospholipid metabolism in human breast cancer cells. Biochimica et Biophysica Acta 1392(2-3): 217-232
Richter, J.; Gullberg, U.; Lantz, M. 1995: TNF-induced superoxide anion production in adherent human neutrophils involves both the p55 and p75 TNF receptor. Journal of Immunology 154(8): 4142-4149
Nakajima, Y.; DelliPizzi, A.M.; Mallouh, C.; Ferreri, N.R. 1996: TNF-mediated cytotoxicity and resistance in human prostate cancer cell lines. Prostate 29(5): 296-302
O'Connell, M.A.; Kelleher, D.; Liskamp, R.M.; Hall, N.; O'Neill, L.A.; Long, A. 1997: TNF-mediated cytotoxicity of L929 cells: role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymes. Cytokine 9(2): 83-92
Orlinick, J.R.; Chao, M.V. 1998: TNF-related ligands and their receptors. Cellular Signalling 10(8): 543-551
Schleiffenbaum, B.; Olgiati, L.; Fehr, J. 1992: TNF-specific deactivation of granulocytes in vivo: A possible mechanism of self-protection. European Journal of Haematology 49(5): 239-245
Wisniewski, H.G.; Hua, J.C.; Poppers, D.M.; Naime, D.; Vilcek, J.; Cronstein, B.N. 1996: TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. Journal of Immunology 156(4): 1609-1615
McManus, R.; Wilson, A.G.; Mansfield, J.; Weir, D.G.; Duff, G.W.; Kelleher, D. 1996: TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. European Journal of Immunology 26(9): 2113-2118
Newton, D.J.; Bowen-Jones, D.; Crosby, I.; Barnes, R.M.; Flanagan, B.F. 1998: TNFB gene polymorphism in insulin-dependent diabetes mellitus: Association with HLA-DR alleles. European Journal of Immunogenetics: Official Journal of the British Society for Histocompatibility and Immunogenetics 25(1): 39-41
Kim, H.Y.; Lee, S.H.; Yang, H.I.; Park, S.H.; Cho, C.S.; Kim, T.G.; Han, H.; Kim, D.J. 1995: TNFB gene polymorphism in patients with systemic lupus erythematosus in Korean. Korean Journal of Internal Medicine 10(2): 130-136
Weissensteiner, T.; Lanchbury, J.S. 1997: TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes. Immunogenetics 47(1): 6-16
Rabbi, M.F.; Al-Harthi, L.; Roebuck, K.A. 1997: TNFalpha cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements. Virology 237(2): 422-429
Lyle, R.E.; Richon, V.M.; McGehee, R.E. 1998: TNFalpha disrupts mitotic clonal expansion and regulation of retinoblastoma proteins p130 and p107 during 3T3-L1 adipocyte differentiation. Biochemical and Biophysical Research Communications 247(2): 373-378
Sata, M.; Walsh, K. 1998: TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nature Medicine 4(4): 415-420
Krupitza, G.; Grusch, M.; Braun, K.; Fuhrmann, G.; Steinbrugger, R.; Hulla, W.; Simonitsch, I.; Chott, A.; Hengstschlager, M. 1998: TNFalpha-mediated cell death is independent of Cdc25A. Cell Death and Differentiation 5(9): 758-764
Cannon, C.P.; McCabe, C.H.; Gibson, C.M.; Ghali, M.; Sequeira, R.F.; McKendall, G.R.; Breed, J.; Modi, N.B.; Fox, N.L.; Tracy, R.P.; Love, T.W.; Braunwald, E. 1997: TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation 95(2): 351-356
Düx, M.; Roeren, T.; Kuntz, C.; Richter, G.M.; Kauffmann, G.W. 1997: TNM staging of gastrointestinal tumors by hydrosonography: Results of a histopathologically controlled study in 60 patients. Abdominal Imaging 22(1): 24-34
Stewart, R.C.; VanBruggen, R.; Ellefson, D.D.; Wolfe, A.J. 1998: TNP-ATP and TNP-ADP as probes of the nucleotide binding site of CheA, the histidine protein kinase in the chemotaxis signal transduction pathway of Escherichia coli. Biochemistry 37(35): 12269-12279
Jorge-Rivera, J.C.; Marder, E. 1996: TNRNFLRFamide and SDRNFLRFamide modulate muscles of the stomatogastric system of the crab Cancer borealis. Journal of Comparative Physiology. A Sensory Neural and Behavioral Physiology 179(6): 741-751
Voldeng, H.D.; Fregeau Reid, J.A.; Guillemette, R.J.D.; Leonard, D.A.; Cober, E.R. 1997: TNS soybean. Canadian Journal of Plant Science 77(1): 117-118
Van Hooijdonk, C.A.; Glade, C.P.; Van Erp, P.E. 1994: TO-PRO-3 iodide: a novel HeNe laser-excitable DNA stain as an alternative for propidium iodide in multiparameter flow cytometry. Cytometry 17(2): 185-189
Toniolo, C.; Crisma, M.; Formaggio, F. 1998: TOAC, a nitroxide spin-labeled, achiral Calpha-tetrasubstituted alpha-amino acid, is an excellent tool in material science and biochemistry. Biopolymers 47(2): 153-158
Minturn, J.E.; Fryer, H.J.; Geschwind, D.H.; Hockfield, S. 1995: TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 15(10): 6757-6766
Hozalski, R.M.; Goel, S.; Bouwer, E.J. 1995: TOC removal in biological filters. Journal - American Water Works Association 87(12): 40-54
Hanaki, H.; Akagi, H.; Masaru, Y.; Otani, T.; Hyodo, A.; Hiramatsu, K. 1995: TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and ChemoTherapy 39(5): 1120-1126
Gray, A.T.; Winegar, B.D.; Leonoudakis, D.J.; Forsayeth, J.R.; Yost, C.S. 1998: TOK1 is a volatile anesthetic stimulated K+ channel. Anesthesiology 88(4): 1076-1084
Kaldalu, N.; Mandel, T.; Ustav, M. 1996: TOL plasmid transcription factor XylS binds specifically to the Pm operator sequence. Molecular Microbiology 20(3): 569-579
Saleh, A.; Collart, M.; Martens, J.A.; Genereaux, J.; Allard, S.; Cote, J.; Brandl, C.J. 1998: TOM1p, a yeast Hect-domain protein which mediates transcriptional regulation through the ADA/SAGA coactivator complexes. Journal of Molecular Biology 282(5): 933-946
Newcomer, T.A.; Rosenberg, P.A.; Aizenman, E. 1995: TOPA quinone, a kainate-like agonist and excitotoxin is generated by a catecholaminergic cell line. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 15(4): 3172-3177
McGuire, G.; Wright, F. 1998: TOPAL: recombination detection in DNA and protein sequences. Bioinformatics 14(2): 219-220
Hatton, T.J.; Dawes, W. 1993: TOPOG-IRM: 2. Example simulations. Australia Commonwealth Scientific and Industrial Research Organization Institute of Natural Resources and Environment Division of Water Resources Technical Memorandum 1993(93-6)
Zheng, X.F.; Florentino, D.; Chen, J.; Crabtree, G.R.; Schreiber, S.L. 1995: TOR Kinase Domains Are Required for Two Distinct Functions, Only One of Which Is Inhibited by Rapamycin. Cell 82(1): 121-130
Barbet, N.C.; Schneider, U.; Helliwell, S.B.; Stansfield, I.; Tuite, M.F.; Hall, M.N. 1996: TOR controls translation initiation and early G1 progression in yeast. Molecular Biology of the Cell 7(1): 25-42
Lorenz, M.C.; Heitman, J. 1995: TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. Journal of Biological Chemistry 270(46): 27531-27537
Helliwell, S.B.; Wagner, P.; Kunz, J.; Deuter-Reinhard, M.; Henriquez, R.; Hall, M.N. 1994: TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Molecular Biology of the Cell 5(1): 105-118
Helliwell, S.B.; Howald, I.; Barbet, N.; Hall, M.N. 1998: TOR2 is part of two related signaling pathways coordinating cell growth in Saccharomyces cerevisiae. Genetics 148(1): 99-112
Schmidt, A.; Kunz, J.; Hall, M.N. 1996: TOR2 is required for organization of the actin cytoskeleton in yeast. Proceedings of the National Academy of Sciences of the United States of America 93(24): 13780-13785
Ortiz, M.A.; Piedrafita, F.J.; Pfahl, M.; Maki, R. 1995: TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals. Molecular Endocrinology 9(12): 1679-1691
Clark, R. 1994: TORS, rock platforms and Debris slopes at Stiperstones, Shropshire, England. Field Studies 8(3): 451-472
Hirons, G.T.; Fawcett, J.J.; Crissman, H.A. 1994: TOTO and YOYO: new very bright fluorochromes for DNA content analyses by flow cytometry. Cytometry 15(2): 129-140
Roe, J.L.; Durfee, T.; Zupan, J.R.; Repetti, P.P.; McLean, B.G.; Zambryski, P.C. 1997: TOUSLED is a nuclear serine/threonine protein kinase that requires a coiled-coil region for oligomerization and catalytic activity. Journal of Biological Chemistry 272(9): 5838-5845
Nagy, S.; Hayde, M.; Panzenböck, B.; Adlassnig, K.P.; Pollak, A. 1997: TOXOPERT-I: Knowledge-based automatic interpretation of serological tests for toxoplasmosis. Computer Methods and Programs in Biomedicine 53(2): 119-133
Rebello, S.S.; Driscoll, E.M.; Lucchesi, B.R. 1997: TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog. Stroke 28(9): 1789-1796
Hamelin, R.; Fléjou, J.F.; Muzeau, F.; Potet, F.; Laurent-Puig, P.; Fékété, F.; Thomas, G. 1994: TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology 107(4): 1012-1018
Legius, E.; Dierick, H.; Wu, R.; Hall, B.K.; Marynen, P.; Cassiman, J.J.; Glover, T.W. 1994: TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes and Cancer 10(4): 250-255
Eyfjörd, J.E.; Thorlacius, S.; Valgardsdottir, R.; Gretarsdottir, S.; Steinarsdottir, M.; Anamthawat-Jonsson, K. 1995: TP53 abnormalities and genetic instability in breast cancer. Acta Oncologica 34(5): 663-667
Kraus, J.A.; Bolln, C.; Wolf, H.K.; Neumann, J.; Kindermann, D.; Fimmers, R.; Forster, F.; Baumann, A.; Schlegel, U. 1994: TP53 alterations and clinical outcome in low grade astrocytomas. Genes Chromosomes and Cancer 10(2): 143-149
Chitemerere, M.; Andersen, T.I.; Holm, R.; Karlsen, F.; Børresen, A.L.; Nesland, J.M. 1996: TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Breast Cancer Research and Treatment 41(2): 103-109
Berns, E.M.; Klijn, J.G.; Smid, M.; van Staveren, I.L.; Look, M.P.; van Putten, W.L.; Foekens, J.A. 1996: TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes and Cancer 16(3): 170-179
Yang, H.K.; Linnoila, R.I.; Conrad, N.K.; Krasna, M.J.; Aisner, S.C.; Johnson, B.E.; Kelley, M.J. 1995: TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract. International Journal of Cancer 64(4): 229-233
Audrézet, M.P.; Robaszkiewicz, M.; Mercier, B.; Nousbaum, J.B.; Bail, J.P.; Hardy, E.; Volant, A.; Lozac'h, P.; Charles, J.F.; Gouéron, H. 1993: TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Research 53(23): 5745-5749
Xu, L.; Davidson, B.J.; Murty, V.V.; Li, R.G.; Sacks, P.G.; Garin-Chesa, P.; Schantz, S.P.; Chaganti, R.S. 1994: TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. International Journal of Cancer 59(3): 383-387
D'Andrea, E.; Baffa, R.; Menin, C.; Montagna, M.; Rugge, M.; Chieco-Bianchi, L. 1995: TP53 gene mutations in gastric carcinoma detected by polymerase chain reaction/single-strand conformation polymorphism analysis of archival material. Journal of Cancer Research and Clinical Oncology 121(2): 79-83
Nagai, M.A.; Miracca, E.C.; Yamamoto, L.; Moura, R.P.; Simpson, A.J.; Kowalski, L.P.; Brentani, R.R. 1998: TP53 genetic alterations in head-and-neck carcinomas from Brazil. International Journal of Cancer 76(1): 13-18
Murphy, M.; McManus, D.T.; Toner, P.G.; Russell, S.E. 1997: TP53 mutation in ovarian carcinoma. European Journal of Cancer 33(8): 1281-1283
Thorlacius, S.; Thorgilsson, B.; Björnsson, J.; Tryggvadottir, L.; Börresen, A.L.; Ogmundsdottir, H.M.; Eyfjörd, J.E. 1995: TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis. European Journal of Cancer 31A(11): 1856-1861
Børresen, A.L.; Andersen, T.I.; Eyfjörd, J.E.; Cornelis, R.S.; Thorlacius, S.; Borg, A.; Johansson, U.; Theillet, C.; Scherneck, S.; Hartman, S. 1995: TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes and Cancer 14(1): 71-75
Yamamoto, L.; Lopes, A.A.; Harb Gama, A.; Nagai, M.A. 1996: TP53 mutations and loss of heterozygosity of chromosome 17 in colorectal tumors. Brazilian Journal of Genetics 19(4): 647-653
Kaneko, H.; Misawa, S.; Horiike, S.; Nakai, H.; Kashima, K. 1995: TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities. Blood 85(8): 2189-2193
Biernat, W.; Debiec-Rychter, M.; Kordek, R.; Liberski, P.P. 1997: TP53 mutations in malignant astrocytomas. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 48(4): 221-224
Berner, A.; Geitvik, G.; Karlsen, F.; Fosså, S.D.; Nesland, J.M.; Børresen, A.L. 1995: TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue. Journal of Pathology 176(3): 299-308
Hanada, K.; Itoh, M.; Fujii, K.; Tsuchida, A.; Hirata, M.; Iwao, T.; Eguchi, N.; Sasaki, T.; Matsubara, K.; Kajiyama, G. 1997: TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns. European Journal of Cancer 33(7): 1136-1140
Skomedal, H.; Kristensen, G.B.; Abeler, V.M.; Børresen-Dale, A.L.; Tropé, C.; Holm, R. 1997: TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage i carcinomas. Journal of Pathology 181(2): 158-165
Basset-Séguin, N.; Molès, J.P.; Mils, V.; Dereure, O.; Guilhou, J.J. 1994: TP53 tumor suppressor gene and skin carcinogenesis. Journal of Investigative Dermatology 103(5 Suppl): 102s-106s
de Bernard, M.; Moschioni, M.; Papini, E.; Telford, J.L.; Rappuoli, R.; Montecucco, C. 1998: TPA and butyrate increase cell sensitivity to the vacuolating toxin of Helicobacter pylori. FEBS Letters 436(2): 218-222
Frawley, B.P.; Tien, X.Y.; Hartmann, S.C.; Wali, R.K.; Niedziela, S.M.; Davidson, N.O.; Sitrin, M.D.; Brasitus, T.A.; Bissonnette, M. 1994: TPA causes divergent responses of Ca(2+)-dependent and Ca(2+)-independent isoforms of PKC in the nuclei of Caco-2 cells. Biochimica et Biophysica Acta 1222(2): 301-305
Kwak, B.R.; van Veen, T.A.; Analbers, L.J.; Jongsma, H.J. 1995: TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels. Experimental Cell Research 220(2): 456-463
Giese, G.; Schmidt, J.; Gilbert, M.; Albrecht, R.; Traub, P. 1997: TPA induces apoptosis in MPC-11 mouse plasmacytoma cells grown in serum-free medium. Biology of the Cell 89(2): 99-111
Kósa, K.; Rosenberg, M.I.; Chiantore, M.V.; De Luca, L.M. 1997: TPA induces transglutaminase C and inhibits cell growth in the colon carcinoma cell line SW620. Biochemical and Biophysical Research Communications 232(3): 737-741
Chen, C.C.; Wang, J.K.; Chen, W.C. 1997: TPA induces translocation but not down-regulation of new PKC isoform eta in macrophages, MDCK cells and astrocytes. Febs Letters 412(1): 30-34
Roseng, L.E.; Rivedal, E. 1993: TPA inhibition of gap junctional intercellular communication in Syrian hamster embryo cells through two different pathways. Toxicology in Vitro: An International Journal Published in Association with Bibra 7(5): 631-636
Filella, X.; Menendez, V.; Molina, R.; Alcover, J.; Carretero, P.; Ballesta, A.M. 1996: TPA prognostic value in superficial bladder cancer. Anticancer Research 16(4b): 2173-2175
Pectasides, D.; Bafaloucos, D.; Antoniou, F.; Gogou, L.; Economides, N.; Varthalitis, J.; Dimitriades, M.; Kosmidis, P.; Athanassiou, A. 1996: TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder. American Journal of Clinical Oncology 19(3): 271-277
Nabeshima, K.; Komada, N.; Kishi, J.; Koita, H.; Inoue, T.; Hayakawa, T.; Koono, M. 1993: TPA-enhanced invasion of matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1. International Journal of Cancer 55(6): 974-981
Kamesaki, H.; Michaud, G.Y.; Irving, S.G.; Suwabe, N.; Kamesaki, S.; Okuma, M.; Cossman, J. 1996: TPA-induced arrest of erythroid differentiation is coupled with downregulation of GATA-1 and upregulation of GATA-2 in an erythroid cell line SAM-1. Blood 87(3): 999-1005
Nabeshima, K.; Inoue, T.; Shimao, Y.; Kataoka, H.; Koono, M. 1998: TPA-induced cohort migration of well-differentiated human rectal adenocarcinoma cells: cells move in a RGD-dependent manner on fibronectin produced by cells, and phosphorylation of E-cadherin/catenin complex is induced independently of cell-extracellular matrix interactions. Virchows Archiv: An International Journal of Pathology 433(3): 243-253
Germani, A.; Fusco, C.; Martinotti, S.; Musarò, A.; Molinaro, M.; Zani, B.M. 1994: TPA-induced differentiation of human rhabdomyosarcoma cells involves dephosphorylation and nuclear accumulation of mutant P53. Biochemical and Biophysical Research Communications 202(1): 17-24
Bouché, M.; Senni, M.I.; Grossi, A.M.; Zappelli, F.; Polimeni, M.; Arnold, H.H.; Cossu, G.; Molinaro, M. 1993: TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors. Experimental Cell Research 208(1): 209-217
Tucker, M.A.; Chang, P.L.; Prince, C.W.; Gillespie, G.Y.; Mapstone, T.B. 1998: TPA-mediated regulation of osteopontin in human malignant glioma cells. Anticancer Research 18(2a): 807-812
Robinson, M.K.; van Zyl, W.H.; Phizicky, E.M.; Broach, J.R. 1994: TPD1 of Saccharomyces cerevisiae encodes a protein phosphatase 2C-like activity implicated in tRNA splicing and cell separation. Molecular and Cellular Biology 14(6): 3634-3645
Kaba, S.E.; Kyritsis, A.P.; Hess, K.; Yung, W.K.; Mercier, R.; Dakhil, S.; Jaeckle, K.A.; Levin, V.A. 1997: TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(3): 1063-1070
Shumaker, D.K.; Vann, L.R.; Goldberg, M.W.; Allen, T.D.; Wilson, K.L. 1998: TPEN, a Zn2+/Fe2+ chelator with low affinity for Ca2+, inhibits lamin assembly, destabilizes nuclear architecture and may independently protect nuclei from apoptosis in vitro. Cell Calcium 23(2-3): 151-164
Aharon, M.; Ben Valid, I.; Dvilansky, A.; Nathan, I. 1995: TPK inhibitors differentially affect IFN-gamma activities. Anticancer Research 15(5b): 2071-2076
Kitamura, K.; Yamaguchi, T.; Tanaka, H.; Hashimoto, S.; Yang, M.; Takahashi, T. 1996: TPN-induced fulminant beriberi: A report on our experience and a review of the literature. Surgery Today 26(10): 769-776
Dorsch, M.; Fan, P.D.; Bogenberger, J.; Goff, S.P. 1995: TPO and IL-3 induce overlapping but distinct protein tyrosine phosphorylation in a myeloid precursor cell line. Biochemical and Biophysical Research Communications 214(2): 424-431
Sasaki, K.; Odai, H.; Hanazono, Y.; Ueno, H.; Ogawa, S.; Langdon, W.Y.; Tanaka, T.; Miyagawa, K.; Mitani, K.; Yazaki, Y. 1995: TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules. Biochemical and Biophysical Research Communications 216(1): 338-347
Krueger, W.H.; Gonye, G.E.; Madison, D.L.; Murray, K.E.; Kumar, M.; Spoerel, N.; Pfeiffer, S.E. 1997: TPO1, a member of a novel protein family, is developmentally regulated in cultured oligodendrocytes. Journal of Neurochemistry 69(4): 1343-1355
Osher, Y.; Cloninger, C.R.; Belmaker, R.H. 1996: TPQ in euthymic manic-depressive patients. Journal of Psychiatric Research 30(5): 353-357
Zachariae, W.; Nasmyth, K. 1996: TPR proteins required for anaphase progression mediate ubiquitination of mitotic B-type cyclins in yeast. Molecular Biology of the Cell 7(5): 791-801
Giai, M.; Roagna, R.; Ponzone, R.; Biglia, N.; Sgro, L.; Perona, M.; Sismondi, P. 1996: TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients. Anticancer Research 16(2): 875-881
Tsikaris, V.; Petit, M.C.; Orlewski, P.; Sakarellos Daitsiotis, M.; Sakarellos, C.; Tzinia, A.; Konidou, G.; Soteriadou, K.P.; Marraud, M.; Cung, M.T. 1997: TR-NOE and MD studies of Leishmania gp63 SRYD-containing sequences bound to anti-SRYD monoclonal antibody. Letters in Peptide Science 4(4-6): 323-330
Kwon, B.S.; Wang, S.; Udagawa, N.; Haridas, V.; Lee, Z.H.; Kim, K.K.; Oh, K.O.; Greene, J.; Li, Y.; Su, J.; Gentz, R.; Aggarwal, B.B.; Ni, J. 1998: TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB Journal 12(10): 845-854
Jacobsen, J.; Pedersen, M.; Rassing, M.-Romer 1996: TR146 cells as a model for human buccal epithelium: II. Optimisation and use of a cellular sensitivity MTS/PMS assay. International Journal of Pharmaceutics (Amsterdam) 141(1-2): 217-225
Jacobsen, J.; Van-Deurs, B.; Pedersen, M.; Rassing, M.-Romer 1995: TR146 cells grown on filters as a model for human buccal epithelium: I. Morphology, growth, barrier properties, and permeability. International Journal of Pharmaceutics (Amsterdam) 125(2): 165-184
Hwang, S.B.; Burbach, J.P.; Chang, C. 1998: TR4 orphan receptor crosstalks to chicken ovalbumin upstream protein-transcription factor and thyroid hormone receptor to induce the transcriptional activity of the human immunodeficiency virus type 1 long-terminal repeat. Endocrine 8(2): 169-175
Grell, M.; Scheurich, P.; Meager, A.; Pfizenmaier, K. 1993: TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine and Cytokine Research 12(3): 143-148
Kasukabe, T.; Okabe-Kado, J.; Honma, Y. 1997: TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines. Blood 89(8): 2975-2985
Hsu, H.; Shu, H.B.; Pan, M.G.; Goeddel, D.V. 1996: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84(2): 299-308
Krajewska, M.; Krajewski, S.; Zapata, J.M.; Van Arsdale, T.; Gascoyne, R.D.; Berern, K.; McFadden, D.; Shabaik, A.; Hugh, J.; Reynolds, A.; Clevenger, C.V.; Reed, J.C. 1998: TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues. American Journal of Pathology 152(6): 1549-1561
Carpentier, I.; Declercq, W.; Malinin, N.L.; Wallach, D.; Fiers, W.; Beyaert, R. 1998: TRAF2 plays a dual role in NF-kappaB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IkappaB kinase pathways. Febs Letters 425(2): 195-198
Rothe, M.; Sarma, V.; Dixit, V.M.; Goeddel, D.V. 1995: TRAF2-mediated activated of NF-kappa-B by TNR receptor 2 and CD40. Science 269(5229): 1424-1427
Ishida, T.K.; Tojo, T.; Aoki, T.; Kobayashi, N.; Ohishi, T.; Watanabe, T.; Yamamoto, T.; Inoue, J. 1996: TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proceedings of the National Academy of Sciences of the United States of America 93(18): 9437-9442
Nakano, H.; Oshima, H.; Chung, W.; Williams-Abbott, L.; Ware, C.F.; Yagita, H.; Okumura, K. 1996: TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. Journal of Biological Chemistry 271(25): 14661-14664
Walczak, H.; Degli-Esposti, M.A.; Johnson, R.S.; Smolak, P.J.; Waugh, J.Y.; Boiani, N.; Timour, M.S.; Gerhart, M.J.; Schooley, K.A.; Smith, C.A.; Goodwin, R.G.; Rauch, C.T. 1997: TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO Journal 16(17): 5386-5397
Jeremias, I.; Herr, I.; Boehler, T.; Debatin, K.M. 1998: TRAIL/Apo-2-ligand-induced apoptosis in human T cells. European Journal of Immunology 28(1): 143-152
Hegde, R.S.; Voigt, S.; Rapoport, T.A.; Lingappa, V.R. 1998: TRAM regulates the exposure of nascent secretory proteins to the cytosol during translocation into the endoplasmic reticulum. Cell 92(5): 621-631
Takeshita, A.; Cardona, G.R.; Koibuchi, N.; Suen, C.S.; Chin, W.W. 1997: TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. Journal of Biological Chemistry 272(44): 27629-27634
Bodmer, J.L.; Burns, K.; Schneider, P.; Hofmann, K.; Steiner, V.; Thome, M.; Bornand, T.; Hahne, M.; Schröter, M.; Becker, K.; Wilson, A.; French, L.E.; Browning, J.L.; MacDonald, H.R.; Tschopp, J. 1997: TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6(1): 79-88
Veklerov, E.; Martin, C.H.; Theil, E.H. 1995: TRAMP: a software package for generating transposon maps. Computer Applications in the Biosciences: Cabios 11(2): 173-179
Wong, B.R.; Rho, J.; Arron, J.; Robinson, E.; Orlinick, J.; Chao, M.; Kalachikov, S.; Cayani, E.; Bartlett, F.S.; Frankel, W.N.; Lee, S.Y.; Choi, Y. 1997: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. Journal of Biological Chemistry 272(40): 25190-25194
Fuller, K.; Wong, B.; Fox, S.; Choi, Y.; Chambers, T.J. 1998: TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. Journal of Experimental Medicine 188(5): 997-1001
Desiato, F.; Finardi, S.; Brusasca, G.; Morselli, M.G. 1998: TRANSALP 1989 experimental campaign: I. Simulation of 3D flow with diagnostic wind field models. Atmospheric Environment 32(7): 1141-1156
Anfossi, D.; Desiato, F.; Tinarelli, G.; Brusasca, G.; Ferrero, E.; Sacchetti, D. 1998: TRANSALP 1989 experimental campaign: II. Simulation of a tracer experiment with Lagragian particle models. Atmospheric Environment 32(7): 1157-1166
Wingender, E.; Kel, A.E.; Kel, O.V.; Karas, H.; Heinemeyer, T.; Dietze, P.; Knüppel, R.; Romaschenko, A.G.; Kolchanov, N.A. 1997: TRANSFAC, TRRD and COMPEL: towards a federated database system on transcriptional regulation. Nucleic Acids Research 25(1): 265-268
Wingender, E.; Dietze, P.; Karas, H.; Knüppel, R. 1996: TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Research 24(1): 238-241
Sultan, A.A.; Thathy, V.; Frevert, U.; Robson, K.J.; Crisanti, A.; Nussenzweig, V.; Nussenzweig, R.S.; Ménard, R. 1997: TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites. Cell 90(3): 511-522
Forward, J.A.; Behrendt, M.C.; Wyborn, N.R.; Cross, R.; Kelly, D.J. 1997: TRAP transporters: a new family of periplasmic solute transport systems encoded by the dctPQM genes of Rhodobacter capsulatus and by homologs in diverse gram-negative bacteria. Journal of Bacteriology 179(17): 5482-5493
Babitzke, P.; Bear, D.G.; Yanofsky, C. 1995: TRAP, the trp RNA-binding attenuation protein of Bacillus subtilis, is a toroid-shaped molecule that binds transcripts containing GAG or UAG repeats separated by two nucleotides. Proceedings of the National Academy of Sciences of the United States of America 92(17): 7916-7920
Sacher, M.; Jiang, Y.; Barrowman, J.; Scarpa, A.; Burston, J.; Zhang, L.; Schieltz, D.; Yates, J.R.; Abeliovich, H.; Ferro-Novick, S. 1998: TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO Journal 17(9): 2494-2503
Magliulo, V.; Renella, G. 1997: TRASOR, a transit time portable system for measuring soil respiration. Computers and Electronics in Agriculture 18(1): 43-54
Griffith, J.; Bianchi, A.; de Lange, T. 1998: TRF1 promotes parallel pairing of telomeric tracts in vitro. Journal of Molecular Biology 278(1): 79-88
van Steensel, B.; Smogorzewska, A.; de Lange, T. 1998: TRF2 protects human telomeres from end-to-end fusions. Cell 92(3): 401-413
Patalan, D.; Kruszyński, M.; Zboińska, J.; Kupryszewski, G.; Grehn, L.; Alexandrová, M.; Strbák, V. 1993: TRH analogs with 4-nitro- and 4-N-butyloxycarbonylamino-1-methyl-2-pyrolylcarboxylic acid in position 1. Synthesis and biological properties. Polish Journal of Pharmacology 45(1): 83-94
Iwasaki, Y.; Ikeda, K.; Shiojima, T.; Kinoshita, M. 1992: TRH analogue, TA-0910 (3-methyl-(s)-5,6-dihydroorotyl-L-histidyl-L-prolinamide) enhances neurite outgrowth in rat embryo ventral spinal cord in vitro. Journal of the Neurological Sciences 112(1-2): 147-151
Krowicki, Z.K.; Hornby, P.J. 1994: TRH and substance P independently affect gastric motility in nucleus raphe obscurus of the rat. American Journal of Physiology 266(5 Pt 1): G870-G877
Yang, H.; Ohning, G.; Taché, Y. 1993: TRH in dorsal vagal complex mediates acid response to excitation of raphe pallidus neurons in rats. American Journal of Physiology 265(5 Pt 1): G880-G886
Kaneko, H.; Taché, Y. 1995: TRH in the dorsal motor nucleus of vagus is involved in gastric erosion induced by excitation of raphe pallidus in rats. Brain Research 699(1): 97-102
Kinoshita, K.; Watanabe, Y.; Yamamura, M.; Matsuoka, Y. 1998: TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats. European Journal of Pharmacology 343(2-3): 129-133
Raiden, S.; Polack, E.; Nahmod, V.; Labeur, M.; Holsboer, F.; Arzt, E. 1995: TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH. Journal of Clinical Immunology 15(5): 242-249
Iwase, M.; Shioda, S.; Nakai, Y.; Iwatsuki, K.; Homma, I. 1992: TRH regulation of tracheal tension through vagal preganglionic motoneurons. Brain Research Bulletin 29(6): 821-829
De la Fuente, J.M.; Mendlewicz, J. 1996: TRH stimulation and dexamethasone suppression in borderline personality disorder. Biological Psychiatry 40(5): 412-418
Amsterdam, J.D.; Fava, M.; Maislin, G.; Rosenbaum, J.; Hornig-Rohan, M. 1996: TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression. Journal of Affective Disorders 38(2-3): 165-172
Marchesi, C.; De Risio, C.; Campanini, G.; Maggini, C.; Piazza, P.; Grassi, M.; Chiodera, P.; Coiro, V. 1992: TRH test in alcoholics: relationship of the endocrine results with neuroradiological and neuropsychological findings. Alcohol and Alcoholism 27(5): 531-537
Törnquist, K.; Ekokoski, E.; Forss, L. 1994: TRH-evoked entry of extracellular calcium in GH4C1 cells: possible importance of arachidonic acid metabolites. Molecular and Cellular Endocrinology 102(1-2): 103-110
Duntas, L.; Glasbrenner, B.; Wolf, C.; Pieramico, O.; Büchler, M.; Malfertheiner, P. 1992: TRH-immunoreactivity in chronic pancreatitis. Hepato-Gastroenterology 39(5): 413-416
Farnsworth, W.E. 1993: TRH: Mediator of prolactin in the prostate?. Medical Hypotheses 41(5): 450-454
Higgins, N.A. 1997: TRIF-An intermediate approach to environmental tritium modelling. Journal of Environmental Radioactivity 36(2-3): 253-267
Wilson, S.A.; Brown, E.C.; Kingsman, A.J.; Kingsman, S.M. 1998: TRIP: a novel double stranded RNA binding protein which interacts with the leucine rich repeat of flightless i. Nucleic Acids Research 26(15): 3460-3467
Azen, S.P.; Peters, R.K.; Berkowitz, K.; Kjos, S.; Xiang, A.; Buchanan, T.A. 1998: TRIPOD (TRoglitazone in the prevention of diabetes): A randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. Controlled Clinical Trials 19(2): 217-231
Cvetkovic, A. 1992: TRISS analysis of trauma care: a Yugoslav perspective. Injury 23(8): 511-514
Chen, E.Y.; Mufson, E.J.; Kordower, J.H. 1996: TRK and p75 neurotrophin receptor systems in the developing human brain. Journal of Comparative Neurology 369(4): 591-618
Okazawa, H.; Nishiyama, K.; Kamei, M.; Washizaki, K.; Murayama, S.; Kwak, S.; Kanazawa, I. 1993: Trk immunoreactivity at neuronal dendrite and cell body. Biochemical and Biophysical Research Communications 194(2): 683-690
Tanahashi, M.; Funaba, Y.; Tateishi, A.; Kawabe, N.; Nakadate-Matsushita, T. 1998: TRK-530 inhibits accumulation of superoxide anions derived from human polymorphonuclear leukocytes and bone resorption induced by activated osteoclasts. Pharmacology 56(3): 125-130
Kordower, J.H.; Chen, E.Y.; Sladek, J.R.; Mufson, E.J. 1994: Trk-immunoreactivity in the monkey central nervous system: forebrain. Journal of Comparative Neurology 349(1): 20-35
Ramos, J.; Alijo, R.; Haro, R.; Rodriguez-Navarro, A. 1994: TRK2 is not a low-affinity potassium transporter in Saccharomyces cerevisiae. Journal of Bacteriology 176(1): 249-252
Grundy, F.J.; Henkin, T.M. 1993: TRNA as a positive regulator of transcription antitermination in Bacillus subtilis. Cell 74(3): 475-482
Servillo, L.; Balestrieri, C.; Quagliuolo, L.; Iorio, E.L.; Giovane, A. 1993: TRNA fluorescent labeling at 3' end inducing an aminoacyl-tRNA-like behavior. European Journal of Biochemistry 213(1): 583-589
Ritter, A.; Blum, G.; Emödy, L.; Kerenyi, M.; Böck, A.; Neuhierl, B.; Rabsch, W.; Scheutz, F.; Hacker, J. 1995: TRNA genes and pathogenicity islands: Influence on virulence and metabolic properties of uropathogenic Escherichia coli. Molecular Microbiology 17(1): 109-121
Hull, M.W.; Erickson, J.; Johnston, M.; Engelke, D.R. 1994: tRNA genes as transcriptional repressor elements. Molecular and Cellular Biology 14(2): 1266-1277
Sedlmeier, R.; Werner, T.; Kieser, H.M.; Hopwood, D.A.; Schmieger, H. 1994: TRNA genes of Streptomyces lividans: new sequences and comparison of structure and organization with those of other bacteria. Journal of Bacteriology 176(17): 5550-5553
Honeycutt, R.J.; Sobral, B.W.; McClelland, M. 1995: TRNA intergenic spacers reveal polymorphisms diagnostic for Xanthomonas albilineans. Microbiology 141: 3229-3239
Sidrauski, C.; Cox, J.S.; Walter, P. 1996: TRNA ligase is required for regulated mRNA splicing in the unfolded protein response. Cell 87(3): 405-413
Burdett, V. 1993: TRNA modification activity is necessary for Tet(M)-mediated tetracycline resistance. Journal of Bacteriology 175(22): 7209-7215
Nekhai, S.A.; Parfenov, D.V.; Saminsky, E.M. 1994: TRNA regions which contact with the ribosomal poly(U)-programmed P-site. Biochimica et Biophysica Acta 1218(3): 481-484
Culver, G.M.; Consaul, S.A.; Tycowski, K.T.; Filipowicz, W.; Phizicky, E.M. 1994: TRNA splicing in yeast and wheat germ. a cyclic phosphodiesterase implicated in the metabolism of ADP-ribose 1",2"-cyclic phosphate. Journal of Biological Chemistry 269(40): 24928-24934
Schultz, D.W.; Yarus, M. 1994: TRNA structure and ribosomal function. II. Interaction between anticodon helix and other tRNA mutations. Journal of Molecular Biology 235(5): 1395-1405
Chong, S.; Curnow, A.W.; Huston, T.J.; Garcia, G.A. 1995: tRNA-guanine transglycosylase from Escherichia coli is a zinc metalloprotein. Site-directed mutagenesis studies to identify the zinc ligands. Biochemistry 34(11): 3694-3701
Brigotti, M.; Carnicelli, D.; Alvergna, P.; Pallanca, A.; Sperti, S.; Montanaro, L. 1996: TRNA(Trp) as cofactor of gelonin, a ribosome-inactivating protein with RNA-N-glycosidase activity. Features required for the cofactor activity. Biochemistry and Molecular Biology International 40(1): 181-188
Henkin, T.M. 1994: tRNA-directed transcription antitermination. Molecular Microbiology 13(3): 381-387
Curnow, A.W.; Kung, F.L.; Koch, K.A.; Garcia, G.A. 1993: TRNA-guanine transglycosylase from Escherichia coli: Gross tRNA structural requirements for recognition. Biochemistry 32(19): 5239-5246
Curnow, A.W.; Garcia, G.A. 1995: TRNA-guanine transglycosylase from Escherichia coli. Minimal tRNA structure and sequence requirements for recognition. Journal of Biological Chemistry 270(29): 17264-17267
Garcia, G.A.; Koch, K.A.; Chong, S. 1993: TRNA-guanine transglycosylase from Escherichia coli. Overexpression, purification and quaternary structure. Journal of Molecular Biology 231(2): 489-497
Curnow, A.W.; Garcia, G.A. 1994: TRNA-guanine transglycosylase from Escherichia coli: recognition of dimeric, unmodified tRNA(Tyr). Biochimie 76(12): 1183-1191
Hoops, G.C.; Townsend, L.B.; Garcia, G.A. 1995: TRNA-guanine transglycosylase from Escherichia coli: structure-activity studies investigating the role of the aminomethyl substituent of the heterocyclic substrate PreQ1. Biochemistry 34(46): 15381-15387
Slany, R.K.; Müller, S.O. 1995: TRNA-guanine transglycosylase from bovine liver. Purification of the enzyme to homogeneity and biochemical characterization. European Journal of Biochemistry 230(1): 221-228
Ushida, C.; Himeno, H.; Watanabe, T.; Muto, A. 1994: tRNA-like structures in 10Sa RNAs of Mycoplasma capricolum and Bacillus subtilis. Nucleic Acids Research 22(16): 3392-3396
Holmes, W.M.; Andraos-Selim, C.; Redlak, M. 1995: TRNA-m1G methyltransferase interactions: touching bases with structure. Biochimie 77(1-2): 62-65
Ehrenberg, M.; Bilgin, N.; Dincbas, V.; Karimi, R.; Hughes, D.; Abdulkarim, F. 1995: TRNA-ribosome interactions. Biochemistry and Cell Biology 73(11-12): 1049-1054
Marquet, R.; Isel, C.; Ehresmann, C.; Ehresmann, B. 1995: TRNAs as primer of reverse transcriptases. Biochimie 77(1-2): 113-124
Lowe, T.M.; Eddy, S.R. 1997: TRNAscan-SE: A program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Research 25(5): 955-964
Pollock, J.A.; Assaf, A.; Peretz, A.; Nichols, C.D.; Mojet, M.H.; Hardie, R.C.; Minke, B. 1995: TRP, a protein essential for inositide-mediated Ca2+ influx is localized adjacent to the calcium stores in Drosophila photoreceptors. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 15(5 Pt 2): 3747-3760
Del Marmol, V.; Ito, S.; Jackson, I.; Vachtenheim, J.; Berr, P.; Ghanem, G.; Morandini, R.; Wakamatsu, K.; Huez, G. 1993: TRP-1 expression correlates with eumelanogenesis in human pigment cells in culture. Febs Letters 327(3): 307-310
Wes, P.D.; Chevesich, J.; Jeromin, A.; Rosenberg, C.; Stetten, G.; Montell, C. 1995: TRPC1, a human homolog of a Drosophila store-operated channel. Proceedings of the National Academy of Sciences of the United States of America 92(21): 9652-9656
Popper, P.; Farber, D.B.; Micevych, P.E.; Minoofar, K.; Bronstein, J.M. 1997: TRPM-2 expression and tunel staining in neurodegenerative diseases: studies in wobbler and rd mice. Experimental Neurology 143(2): 246-254
Russo, P.; Warner, J.A.; Huryk, R.; Perez, G.; Heston, W.D. 1994: TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin. Prostate 24(5): 237-243
Kel', A.E.; Kolchanov, N.A.; Kel', O.V.; Romashchenko, A.G.; Anan'ko, E.A.; Ignat'eva, E.V.; Merkulova, T.I.; Podkolodnaya, O.A.; Stepanenko, I.L.; Kochetov, A.V.; Kolpakov, F.A.; Podkolodnyi, N.L.; Naumochkin, A.A. 1997: TRRD: Database on transcription regulatory regions of eukaryotic genes. Molekulyarnaya biologia 31(4): 626-636
Pan, G.; Ni, J.; Yu, G.; Wei, Y.F.; Dixit, V.M. 1998: TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Letters 424(1-2): 41-45
Joly, E.C.; Tremblay, E.; Tanguay, R.M.; Wu, Y.; Bibor-Hardy, V. 1994: TRiC-P5, a novel TCP1-related protein, is localized in the cytoplasm and in the nuclear matrix. Journal of Cell Science 107: 2851-2859
Camarasa, M.-Jose; Perez-Perez, M.-Jesus; Velazquez, S.; San-Felix, A.; Alvarez, R.; Ingate, S.; Jimeno, M.-Luisa; Karlsson, A.; De-Clercq, E.; Balzarini, J. 1995: TSAO derivatives: Highly specific inhibitors of human immunodeficiency virus type-1 (HIV-1) replication. Nucleosides and Nucleotides 14(3-5): 585-594
Ohashi, T.; Sato, S.; Yoshiki, A.; Kusakabe, M. 1997: TSC-36 (Follistatin-related polypeptide) gene expression in estrogen receptor positive osteoblastic cell line, CDO7F. Calcified Tissue International 61(5): 400-403
Reid, M.E.; Moore, B.P.; Poole, J.; Parker, N.J.; Asenbryl, E.; Vengelen-Tyler, V.; Lubenko, A.; Galligan, B. 1992: TSEN: A novel MNS-related blood group antigen. Vox Sanguinis 63(2): 122-128
Chen, S.; West, R.W.; Ma, J.; Johnson, S.L.; Gans, H.; Woldehawariat, G. 1993: TSF1 to TSF6, required for silencing the Saccharomyces cerevisiae GAL genes, are global regulatory genes. Genetics 134(3): 701-716
Lee, G.W.; Lee, T.H.; Vilcek, J. 1993: TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. Journal of Immunology 150(5): 1804-1812
Maier, R.; Wisniewski, H.G.; Vilcek, J.; Lotz, M. 1996: TSG-6 expression in human articular chondrocytes. Possible implications in joint inflammation and cartilage degradation. Arthritis and Rheumatism 39(4): 552-559
Parkar, A.A.; Kahmann, J.D.; Howat, S.L.; Bayliss, M.T.; Day, A.J. 1998: TSG-6 interacts with hyaluronan and aggrecan in a pH-dependent manner via a common functional element: Implications for its regulation in inflamed cartilage. FEBS Letters 428(3): 171-176
Wisniewski, H.G.; Burgess, W.H.; Oppenheim, J.D.; Vilcek, J. 1994: TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-alpha-inhibitor. Biochemistry 33(23): 7423-7429
Wisniewski, H.G.; Maier, R.; Lotz, M.; Lee, S.; Klampfer, L.; Lee, T.H.; Vilcek, J. 1993: TSG-6: a TNF-, IL-1-, and LPS-inducible secreted glycoprotein associated with arthritis. Journal of Immunology 151(11): 6593-6601
Ben Abdelkhalek, M.; Breton, M.F.; Feliers, D.; Haye, B.; Pavlovic-Hournac, M. 1994: TSH action on cAMP binding to the regulatory subunits of cAMP-dependent protein kinases in pig thyroid cell cultures. Molecular and Cellular Endocrinology 99(1): 103-110
Souza, Fabio Gomes, D.Matos, E. 1996: TSH and T4 levels in affective disorders evaluated by meta-analysis. Revista ABP-APAL (Associacao Brasileira de Psiquiatria-Asociacion Psiquiatrica de la America Latina) 18(1): 9-16
Chang, T.C.; Wu, S.L.; Hsiao, Y.L.; Kuo, S.T.; Chien, L.F.; Kuo, Y.F.; Change, C.C.; Chang, T.J. 1994: TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor. Clinical Immunology and Immunopathology 71(1): 113-120
Valensi, P.; Combes, M.E.; Perret, G.; Attali, J.R. 1996: TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome. Journal of Endocrinological Investigation 19(5): 293-297
Peele, M.E.; Carr, F.E.; Baker, J.R.; Wartofsky, L.; Burman, K.D. 1993: TSH beta subunit gene expression in human lymphocytes. American Journal of the Medical Sciences 305(1): 1-7
Iitaka, M.; Momotani, N.; Hisaoka, T.; Noh, J.Y.; Ishikawa, N.; Ishii, J.; Katayama, S.; Ito, K. 1998: TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis. Clinical Endocrinology 48(4): 445-453
Mengistu, M.; Lukes, Y.G.; Nagy, E.V.; Burch, H.B.; Carr, F.E.; Lahiri, S.; Burman, K.D. 1994: TSH receptor gene expression in retroocular fibroblasts. Journal of Endocrinological Investigation 17(6): 437-441
Duprez, L.; Parma, J.; Van Sande, J.; Rodien, P.; Dumont, J.E.; Vassart, G.; Abramowicz, M. 1998: TSH receptor mutations and thyroid disease. Trends in Endocrinology and Metabolism 9(4): 133-140
Kellermann, S.A.; McCormick, D.J.; Freeman, S.L.; Morris, J.C.; Conti-Fine, B.M. 1995: TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls. Journal of Autoimmunity 8(5): 685-698
Ikeda, H.; Greer, M.A. 1993: TSH secretory responses to prolonged infusion of TRH in hypothyroid rats. Endocrine Journal 40(3): 289-295
Maini, C.L.; Sciuto, R.; Tofani, A. 1994: TSH suppression by octreotide in differentiated thyroid carcinoma. Clinical Endocrinology 40(3): 335-339
Pujol, P.; Osman, A.; Grabar, S.; Daurès, J.P.; Galtier-Dereure, F.; Boegner, C.; Baldet, L.; Raye, R.; Bringer, J.; Jaffiol, C. 1998: TSH suppression combined with carbimazole for Graves' disease: Effect on remission and relapse rates. Clinical Endocrinology 48(5): 635-640
Sato, M.; Kanai, N.; Kanai, H.; Sugase, T.; Hanada, M.; Hayakawa, T.; Saito, Y.; Oonishi, T.; Oda, Y.; Miyagawa, J. 1995: TSH-secreting fibrous pituitary adenoma showing calcification: a case report. No Shinkei Geka. Neurological Surgery 23(3): 259-263
Ottevanger, P.B.; Hermus, A.R.; Smals, A.G.; Kloppenborg, P.W. 1992: TSH-dependent production of T4 and T3 by metastases of a thyroid carcinoma. Acta Endocrinologica 127(5): 413-415
Di Jeso, B.; Gentile, F. 1992: TSH-induced galactose incorporation at the NH2 terminus of thyroglobulin secreted by FRTL-5 cells. Biochemical and Biophysical Research Communications 189(3): 1624-1630
Liu, Z.; Running, M.P.; Meyerowitz, E.M. 1997: TSO1 functions in cell division during Arabidopsis flower development. Development 124(3): 665-672
Charlton, M.; Adjei, P.; Poterucha, J.; Zein, N.; Moore, B.; Therneau, T.; Krom, R.; Wiesner, R. 1998: TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 28(3): 839-842
Fabbro, D.; Di Loreto, C.; Stamerra, O.; Beltrami, C.A.; Lonigro, R.; Damante, G. 1996: TTF-1 gene expression in human lung tumours. European Journal of Cancer 32A(3): 512-517
Di Loreto, C.; Puglisi, F.; Di Lauro, V.; Damante, G.; Beltrami, C.A. 1998: TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Letters 124(1): 73-78
Minoo, P.; Hamdan, H.; Bu, D.; Warburton, D.; Stepanik, P.; deLemos, R. 1995: TTF-1 regulates lung epithelial morphogenesis. Developmental Biology 172(2): 694-698
Pouillon, V.; Pichon, B.; Donda, A.; Christophe, D. 1998: TTF-2 does not appear to be a key mediator of the effect of cyclic AMP on thyroglobulin gene transcription in primary cultured dog thyrocytes. Biochemical and Biophysical Research Communications 242(2): 327-331
Zannini, M.; Avantaggiato, V.; Biffali, E.; Arnone, M.I.; Sato, K.; Pischetola, M.; Taylor, B.A.; Phillips, S.J.; Simeone, A.; Di Lauro, R. 1997: TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO Journal 16(11): 3185-3197
Längst, G.; Becker, P.B.; Grummt, I. 1998: TTF-I determines the chromatin architecture of the active rDNA promoter. EMBO Journal 17(11): 3135-3145
Khan, Golam Faruque 1997: TTF-TCNQ complex based printed biosensor for long-term operation. Electroanalysis 9(4): 325-329
Golderer, G.; Dlaska, M.; Gröbner, P.; Piendl, W. 1995: TTG serves as an initiation codon for the ribosomal protein MvaS7 from the archaeon Methanococcus vannielii. Journal of Bacteriology 177(20): 5994-5996
Ekshiyan, A.Y.; Livshits, L.A.; Kravchenko, S.A.; Mel'nik, V.V.; Musienko, S.I.; Grishko, V.I. 1995: TTGA-tandem repeats allelic polymorphism of dystrophin gene among healthy volunteers from different regions of Ukraine and DMD-families. Biopolimery i Kletka 11(6): 108-112
Konishi, H.; Okuno, T.; Nishiyama, S.; Yamamura, S.; Koyasu, K.; Terada, Y. 1996: TTN oxidation of mixed halogenated phenols: Synthesis of vancomycin model diaryl ether possessing a chlorine atom. Tetrahedron Letters 37(48): 8791-8794
Kaneko, Y.; Matsumoto, G.; Hanyu, Y. 1997: TTX resistivity of Na+ channel in newt retinal neuron. Biochemical and Biophysical Research Communications 240(3): 651-656
Sakai, H.; Saito, T. 1996: TTX-insensitive sodium current develops in adult newt pigment epithelial cells in culture. Zoological Science 13(1): 47-53
Yamazaki, S.; Inouye, S.T.; Kuroda, Y. 1995: TTX-resistant Ca2+ oscillation in cultured hypothalamus: similarity to the mammalian circadian pacemaker. Neuroreport 6(9): 1306-1308
Gu, X.Q.; Dib-Hajj, S.; Rizzo, M.A.; Waxman, S.G. 1997: TTX-sensitive and -resistant Na+ currents, and mRNA for the TTX-resistant rH1 channel, are expressed in B104 neuroblastoma cells. Journal of Neurophysiology 77(1): 236-246
Turner, R.W.; Maler, L.; Deerinck, T.; Levinson, S.R.; Ellisman, M.H. 1994: TTX-sensitive dendritic sodium channels underlie oscillatory discharge in a vertebrate sensory neuron. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 14(11 Part 1): 6453-6471
Amosenko, F.A.; Trubnikova, I.S.; Zakhar'ev, V.M.; Bannikov, V.M.; Sazonova, M.A.; Petrova, N.V.; Kapranov, N.I.; Kaplinin, V.N. 1997: TUB9 polymorphism in the CFTR gene of cystic fibrosis patients, carriers, and healthy donors from the Moscow region. SSCP and restriction analyses. Genetika 33(2): 257-261
Leuschner, U.; Guldutuna, S.; Bhatti, S.; Elze, A.; Imhof, M.; You, T.; Zimmer, G. 1995: TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects. Italian Journal of Gastroenterology 27(7): 376-377
Cerruti, G.; Tani, F. 1994: TUIP for infravesically obstructed BPH patients: a review of 300 cases. Archivos Espanoles de Urologia 47(9): 911-914
Schulze, H. 1995: TULIP: Transurethral ultrasound-guided laser-induced prostatectomy. World Journal of Urology 13(2): 94-97
Gawlik, B.; Druges, M.; Bianchi, M.; Bortoli, A.; Kettrup, A.; Muntau, H. 1997: TUNA FISH (T-30): A new proficiency testing material for the determination of As and Hg in seafood. Fresenius' Journal of Analytical Chemistry 358(3): 441-445
Labat-Moleur, F.; Guillermet, C.; Lorimier, P.; Robert, C.; Lantuejoul, S.; Brambilla, E.; Negoescu, A. 1998: TUNEL apoptotic cell detection in tissue sections: Critical evaluation and improvement. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 46(3): 327-334
Kerrigan, L.A.; Zack, D.J.; Quigley, H.A.; Smith, S.D.; Pease, M.E. 1997: TUNEL-positive ganglion cells in human primary open-angle glaucoma. Archives of Ophthalmology 115(8): 1031-1035
Vicente-Rodriguez, J.; Sanchez-Martin, F.; Redorta, J.P.lou 1994: TURP versus TUIP for BPH: A critical review. Archivos Espanoles de Urologia 47(9): 915-924
Shimai, S.; Yamada, F.; Masuda, K.; Tada, M. 1993: TV game play and obesity in Japanese school children. Perceptual and Motor Skills 76(3 Part 2): 1121-1122
Schiefer, U.; Gisolf, A., C.; Kirsch, J.; Selbmann, H.-Konrad; Zrenner, E. 1996: TV screening for scotomas with noise field campimetry. Results of a field study. Ophthalmologe 93(5): 604-616
Lindquist, K.; Mcgee, M.; Cole, L. 1996: TVA-EPRI River Resource Aid (TERRA) reservoir and power operations decision support system. Water Air and Soil Pollution 90(1-2): 143-150
Batterman, S.; Peng, C.-Ung 1995: TVOC and CO-2 concentrations as indicators in indoor air quality studies. American Industrial Hygiene Association Journal 56(1): 55-65
Dou, C.; Ye, X.; Stewart, C.; Lai, E.; Li, S.C. 1997: TWH regulates the development of subsets of spinal cord neurons. Neuron 18(4): 539-551
Lesage, F.; Guillemare, E.; Fink, M.; Duprat, F.; Lazdunski, M.; Romey, G.; Barhanin, J. 1996: TWIK-1, a ubiquitous human weakly inward rectifying K+ channel with a novel structure. EMBO Journal 15(5): 1004-1011
Williams, C.J.; Christian, J.C.; Norton, J.A. 1992: TWINAN90: a FORTRAN program for conducting ANOVA-based and likelihood-based analyses of twin data. Computer Methods and Programs in Biomedicine 38(2-3): 167-176
Bendiab, O.; Cherruault, Y. 1997: TWONE: The revisited version. Kybernetes 26(8-9): 1047-1055
Hsu, K.S.; Huang, C.C.; Kan, W.M.; Gean, P.W. 1996: TXA2 agonists inhibit high-voltage-activated calcium channels in rat hippocampal CA1 neurons. American Journal of Physiology 271(4 Part 1): C1269-C1277
Haire, R.N.; Ohta, Y.; Lewis, J.E.; Fu, S.M.; Kroisel, P.; Litman, G.W. 1994: TXK, a novel human tyrosine kinase expressed in T cells shares sequence identity with Tec family kinases and maps to 4p12. Human Molecular Genetics 3(6): 897-901
Kim, J.I.; Takahashi, M.; Ohtake, A.; Wakamiya, A.; Sato, K. 1995: Tyr13 is essential for the activity of omega-conotoxin MVIIA and GVIA, specific N-type calcium channel blockers. Biochemical and Biophysical Research Communications 206(2): 449-454
Knäblein, J.; Neuefeind, T.; Schneider, F.; Bergner, A.; Messerschmidt, A.; Löwe, J.; Steipe, B.; Huber, R. 1997: Ta6Br(2+)12, a tool for phase determination of large biological assemblies by X-ray crystallography. Journal of Molecular Biology 270(1): 1-7
Schneider, G.; Lindqvist, Y. 1994: Ta6Br14 is a useful cluster compound for isomorphous replacement in protein crystallography. Acta Crystallographica. Section D Biological Crystallography 50(Part 2): 186-191
Bringmann, G.; God, R.; Feineis, D.; Janetzky, B.; Reichmann, H. 1995: TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain. Journal of Neural Transmission. Supplementum 46: 245-254
Gorayeb, Inocencio-De-Sousa 1993: Tabaniae (Diptera) from the Amazon: XI. Seasonal activity of species from the eastern Amazon and correlation with climatic factors. Boletim do Museu Paraense Emilio Goeldi Serie Zoologia 9(2): 241-281
Rafael, J.A.; Gorayeb, I.S.; Rosa, M.S.S.; Henriques, A.L. 1991: Tabanidae (Diptera) from Maraca Island and the Pacaraima Mountains, Roraima, Brazil, with description of two new species. Acta Amazonica 21(1): 351-367
Ellis, S.E. 1993: Tabanidae as dietary items of Rafinesque's big-eared bat: Implications for its foraging behavior. Entomological News 104(3): 118-122
El-Fatimi, A.; Mkinsi, O.; Etaouil, N.; Benyabya, E.; Janani, S.; Bennis, R. 1997: Tabetic arthropathy of the knee. A four cases report. Rhumatologie 49(1): 22-26
Aguiar, Jaime Paive Lopes 1996: Table of nutrient composition of Amazonian foods. Acta Amazonica 26(1-2): 121-126
Suarez Lopez, M.P.; Ruiz Lopez, D.; Fatima Olea Serrano, M. 1996: Table of standard rations for the interpretation of rural diet surveys. Alimentaria 34(270): 43-46
Barton, M. 1995: Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula. International Journal of Radiation Oncology Biology Physics 31(2): 371-378
Ferrero, M.C.; Munoz, M.; Munoz, A.; Jimenez-Castellanos, M.R. 1996: Tablet excipients: Disintegrants. I. Action mechanisms. Ciencia Pharmaceutica 6(6): 281-288
Ferrero-Rodriguez, M.C.; Munoz-Munoz, N.; Munoz-Ruiz, A.; Jimenez-Castellanos-Ballesteros, M.R. 1997: Tablet excipients: Disintegrants. II. Effect of elaboration process and the excipients in the tablet disintegration. Ciencia Pharmaceutica 7(1): 3-11
Huryeyeva, S.M.; Hroshovyi, T.A.; Burzunov, Y.Y.; Kazarinov, M.O.; Demchenko, V.O.; Sukhovyi, H.F. 1994: Tablet manufacture: Communication III: Auxiliary substances in tablet manufacture by wet granulation. Farmatsevtychnyi Zhurnal (Kiev) 1994(4): 79-84
Adolfsson, A.; Nystrom, C. 1996: Tablet strength, porosity, elasticity and solid state structure of tablets compressed at high loads. International Journal of Pharmaceutics (Amsterdam) 132(1-2): 95-106
Tanino, T.; Aoki, Y.; Sato, K.; Takeda, T.; Mizuta, T. 1995: Tablet weight variation in wet granule compression and a method to decrease variation. Yakuzaigaku 55(2): 114-121
Dedov, I.I.; Gerasimov, G.A.; Sviridenko, N.Y.; Shishkina, A.A.; Maiorova, N.M.; Arbuzova, M.I.; Mishchenko, B.P. 1998: Tableted iodine preparations for the prevention of endemic goiter. Problemy Endokrinologii 44(1): 24-27
Torrado-Durán, J.J.; Torrado, S.; Cadórniga, R.; Augsburger, L.L. 1995: Tableting characteristics of micro-aggregated egg albumin particles containing paracetamol. Journal of Pharmacy and Pharmacology 47(2): 115-119
Yao, T.; Yamada, M.; Yamahara, H.; Yoshida, M. 1997: Tableting of coated particles. I. Small particle size chitosan as an agent protecting coating membrane from mechanical damage of compression force. Chemical and Pharmaceutical Bulletin 45(9): 1510-1514
Yao, T.; Yamada, M.; Yamahara, H.; Yoshida, M. 1998: Tableting of coated particles. II. Influence of particle size of pharmaceutical additives on protection of coating membrane from mechanical damage during compression process. Chemical and Pharmaceutical Bulletin 46(5): 826-830
Bodmeier, R. 1997: Tableting of coated pellets. European Journal of Pharmaceutics and Biopharmaceutics 43(1): 1-8
Morishima, K.; Kawashima, Y.; Takeuchi, H.; Niwa, T.; Hino, T.; Kawashima, Y. 1994: Tabletting properties of bucillamine agglomerates prepared by the spherical crystallization technique. International Journal of Pharmaceutics (Amsterdam) 105(1): 11-18
Leskinen, E.; Hallfors, G. 1997: Tabularia waernii (Diatomophyceae) in the northern Baltic Sea. Annales Botanici Fennici 34(2): 141-147
Gupta, A.; Robinson, N.J.; Robinson, P.J. 1995: Tabulation of thirty-one putative new genes from cyanobacteria. Plant molecular biology 29(3): 617-620
Williams, R.R.; Hunt, S.C.; Hopkins, P.N.; Hasstedt, S.J.; Wu, L.L.; Lalouel, J.M. 1994: Tabulations and expectations regarding the genetics of human hypertension. Kidney International. Supplement 44: S57-S64
Sato, H.; Sugimoto, I.; Matsunaga, T.; Tsuchimoto, M.; Ohta, T.; Uno, H.; Kiyoki, M. 1996: Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice. Archives of Dermatological Research 288(11): 656-663
Van de Kerkhof, P.C.; Werfel, T.; Haustein, U.F.; Luger, T.; Czarnetzki, B.M.; Niemann, R.; Plänitz-Stenzel, V. 1996: Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. British Journal of Dermatology 135(5): 758-765
Iapalucci, S.; Cherñavsky, A.; Rossi, C.; Burgín, M.J.; Franze-Fernández, M.T. 1994: Tacaribe virus gene expression in cytopathic and non-cytopathic infections. Virology 200(2): 613-622
Vrabec, T.R.; Augsburger, J.J.; Fischer, D.H.; Belmont, J.B.; Tashayyod, D.; Israel, H.L. 1995: Taches de Bougie. Ophthalmology 102(11): 1712-1721
Draber-Monko, A. 1993: Tachinid flies (Diptera, Tachinidae) of the Swietokrzyski Region. Fragmenta Faunistica (Warsaw): 3613-18: 275-328
Zeegers, T. 1997: Tachinid flies (Diptera: Tachinidae) from Dutch Thaumetopoea processionea. Entomologische Berichten 57(5): 73-78
Gonzalez, C.R. 1992: Tachinid flies from the Reserva Nacional de Rio Clarillo (Diptera: Tachinidae). Acta Entomologica Chilena 17: 175-185
Richter, V., A.; Wood, D.M.nty 1995: Tachinidae (Diptera) from Yakutia, with description of two new species. Acta Zoologica Fennica 1995(199): 37-48
Tschorsnig, Hans-Peter 1997: Tachinidae (Diptera) recorded from the Swiss National Parc and adjacent parts, collected by Fred Keiser. Mitteilungen der Schweizerischen Entomologischen Gesellschaft 70(1-2): 101-116
Nakajima, H.; Akasaka, T.; Ohkuma, Y.; Minami, K.; Toyoshima, T. 1997: Tachyarrhythmia automatic diagnosis for ICDs. Japanese Journal of Artificial Organs 26(1): 56-60
Almeida-Filho, O., C.; Leal, M., G.; Schmidt, A.; Maciel, B., C.; Marin-Neto, J., A. 1992: Tachyarrhythmias: Clinical management. Medicina (Ribeirao Preto) 25(4): 374-379
Arnolda, L.F.; Pilowsky, P.M.; Minson, J.B.; Llewellyn-Smith, I.J.; Chalmers, J.P. 1996: Tachycardia after glutamate injection in rat spinal cord is not blocked by kynurenate or mimicked by metabotropic agonists. Clinical and Experimental Pharmacology and Physiology 23(9): 813-818
Huang, Y.F.; Zheng, D.; Upton, R.N.; Gray, E.; Grant, C. 1998: Tachycardia alone fails to change the myocardial pharmacokinetics and dynamics of lidocaine, thiopental, and verapamil after intravenous bolus administration in sheep. Journal of Pharmaceutical Sciences 87(7): 854-858
Ciccone, M.; Federici, A.; di Noia, D.; Cipressa, A.; Epifani, M.; Losano, G.; Rizzon, P. 1993: Tachycardia and coronary blood flow: Non-invasive estimation during Valsalva manoeuvre and exercise. Clinical Physiology 13(5): 525-533
Seligman, S.P.; Young, B.K. 1996: Tachycardia as the sole fetal heart rate abnormality after funipuncture. Obstetrics and Gynecology 87(5 Pt 2): 833-834
Porsa, E.; Freeman, G.L.; Herlihy, J.T. 1994: Tachycardia heart failure alters rabbit aortic smooth muscle responsiveness to angiotensin II. American Journal of Physiology 266(3 Pt 2): H1228-H1232
Zupan, I.; Rakovec, P.; Budihna, N.; Brecelj, A.; Kozelj, M. 1996: Tachycardia induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardia. International Journal of Cardiology 56(1): 75-81
Domenech, R.J.; Macho, P.; Vélez, D.; Sánchez, G.; Liu, X.; Dhalla, N. 1998: Tachycardia preconditions infarct size in dogs: role of adenosine and protein kinase C. Circulation 97(8): 786-794
Cleary, R.M.; Ayon, D.; Moore, N.B.; DeBoe, S.F.; Mancini, G.B. 1992: Tachycardia, contractility and volume loading alter conventional indexes of coronary flow reserve, but not the instantaneous hyperemic flow versus pressure slope index. Journal of the American College of Cardiology 20(5): 1261-1269
Ott, P.; Kelly, P.A.; Mann, D.E.; Damle, R.S.; Reiter, M.J.; Lindefeld, J. 1995: Tachycardia-Induced Cardiomyopathy in a Cardiac Transplant Recipient: Treatment with Radiofrequency Catheter Ablation. Journal of Cardiovascular Electrophysiology 6(5): 391-395
Gallagher, M.M.; Obel, O.A.; Camm, J.A. 1997: Tachycardia-induced atrial myopathy: An important mechanism in the pathophysiology of atrial fibrillation?. Journal of Cardiovascular Electrophysiology 8(9): 1065-1074
Vijgen, J.; Hill, P.; Biblo, L.A.; Carlson, M.D. 1997: Tachycardia-induced cardiomyopathy secondary to right ventricular outflow tract ventricular tachycardia: Improvement of left ventricular systolic function after radiofrequency catheter ablation of the arrhythmia. Journal of Cardiovascular Electrophysiology 8(4): 445-450
Shinbane, J.S.; Wood, M.A.; Jensen, D.N.; Ellenbogen, K.A.; Fitzpatrick, A.P.; Scheinman, M.M. 1997: Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. Journal of the American College of Cardiology 29(4): 709-715
Yu, W.C.; Chen, S.A.; Lee, S.H.; Tai, C.T.; Feng, A.N.; Kuo, B.I.; Ding, Y.A.; Chang, M.S. 1998: Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs. Circulation 97(23): 2331-2337
Ravens, U.; Davia, K.; Davies, C.H.; O'Gara, P.; Drake-Holland, A.J.; Hynd, J.W.; Noble, M.I.; Harding, S.E. 1996: Tachycardia-induced failure alters contractile properties of canine ventricular myocytes. Cardiovascular Research 32(3): 613-621
Julius, S.; Palatini, P.; Nesbitt, S.D. 1998: Tachycardia: an important determinant of coronary risk in hypertension. Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 16(1): S9-15
Jiao, Z.; Deng, H.; Jiang, X. 1997: Tachycardiomyopathy induced by recurrent tachycardia in patients with Wolff-Parkinson-White syndrome. Zhonghua Xinxueguanbing Zazhi 25(5): 334-336
Kawabata, S.; Nagayama, R.; Hirata, M.; Shigenaga, T.; Agarwala, K.L.; Saito, T.; Cho, J.; Nakajima, H.; Takagi, T.; Iwanaga, S. 1996: Tachycitin, a small granular component in horseshoe crab hemocytes, is an antimicrobial protein with chitin-binding activity. Journal of Biochemistry 120(6): 1253-1260
Maggi, C.A.; Patacchini, R.; Bartho, L.; Holzer, P.; Santicioli, P. 1994: Tachykinin NK1 and NK2 receptor antagonists and atropine-resistant ascending excitatory reflex to the circular muscle of the guinea-pig ileum. British Journal of Pharmacology 112(1): 161-168
Barthó, L.; Maggi, C.A.; Wilhelm, M.; Patacchini, R. 1994: Tachykinin NK1 and NK2 receptors mediate atropine-resistant ileal circular muscle contractions evoked by capsaicin. European Journal of Pharmacology 259(2): 187-193
Zagorodnyuk, V.; Maggi, C.A. 1997: Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the guinea-pig stomach. Neuroscience 80(2): 625-634
Zagorodnyuk, V.; Santicioli, P.; Turini, D.; Maggi, C.A. 1997: Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the human ileum. Neuropeptides 31(3): 265-271
Boni, P.; Ballati, L.; Evangelista, S. 1995: Tachykinin NK1 and NK2 receptors mediate the non-cholinergic bronchospastic response to capsaicin and vagal stimulation in guinea-pigs. Journal of Autonomic Pharmacology 15(1): 49-54
Zagorodnyuk, V.; Santicioli, P.; Maggi, C.A. 1993: Tachykinin NK1 but not NK2 receptors mediate non-cholinergic excitatory junction potentials in the circular muscle of guinea-pig colon. British Journal of Pharmacology 110(2): 795-803
Ma, Q.P.; Woolf, C.J. 1997: Tachykinin NK1 receptor antagonist RP67580 attenuates progressive hypersensitivity of flexor reflex during experimental inflammation in rats. European Journal of Pharmacology 322(2-3): 165-171
Meini, S.; Patacchini, R.; Maggi, C.A. 1994: Tachykinin NK1 receptor subtypes in the rat urinary bladder. British Journal of Pharmacology 111(3): 739-746
Patacchini, R.; Maggi, C.A. 1995: Tachykinin NK1 receptors mediate both vasoconstrictor and vasodilator responses in the rabbit isolated jugular vein. European Journal of Pharmacology 283(1-3): 233-240
Montuschi, P.; Currò, D.; Ciabattoni, G. 1996: Tachykinin NK2 receptor antagonists decrease eicosanoid release in lung anaphylaxis. European Journal of Pharmacology 313(1-2): R1-R3
Advenier, C. 1995: Tachykinin NK2 receptors further characterized in the lung with nonpeptide receptor antagonists. Canadian Journal of Physiology and Pharmacology 73(7): 878-884
Zeng, X.P.; Burcher, E. 1996: Tachykinin NK-2 receptors in child urinary bladder. Journal of Urology 155(3): 1104-1107
Smith, M.E.; Flynn, F.W. 1994: Tachykinin NK3 receptor agonist blocks sodium deficiency-induced shift in taste reactivity. Brain Research 665(1): 123-126
Maggi, C.A.; Zagorodnyuk, V.; Giuliani, S. 1994: Tachykinin NK3 receptor mediates NANC hyperpolarization and relaxation via nitric oxide release in the circular muscle of the guinea-pig colon. Regulatory Peptides 53(3): 259-274
Holzer, P.; Lippe, I.T.; Heinemann, A.; Barthó, L. 1998: Tachykinin NK1 and NK2 receptor-mediated control of peristaltic propulsion in the guinea-pig small intestine in vitro. Neuropharmacology 37(1): 131-138
Hahn, M.K.; Bannon, M.J. 1998: Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus. European Journal of Pharmacology 348(2-3): 155-160
Corboz, M.R.; Rivelli, M.A.; Ramos, S.I.; Rizzo, C.A.; Hey, J.A. 1998: Tachykinin NK1 receptor-mediated vasorelaxation in human pulmonary arteries. European Journal of Pharmacology 350(1): R1-R3
Tramontana, M.; Patacchini, R.; Lecci, A.; Giuliani, S.; Maggi, C.A. 1998: Tachykinin NK2 receptors in the hamster urinary bladder: In vitro and in vivo characterization. Naunyn-Schmiedeberg's Archives of Pharmacology 358(3): 293-300
Reynolds, A.M.; Reynolds, P.; Holmes, M.; Scicchitano, R. 1998: Tachykinin NK2 receptors predominantly mediate tachykinin-induced contractions in ovine trachea. European Journal of Pharmacology 341(2-3): 211-223
Renzetti, A.R.; Criscuoli, M.; Maggi, C.A. 1997: Tachykinin NK2 receptors: Characterization in the rat small intestine by the use of a peptide agonist and a nonpeptide antagonist as radioligands. Naunyn-Schmiedeberg's Archives of Pharmacology 356(1): 139-144
King, A.E.; Slack, J.R.; Lopez-Garcia, J.A.; Ackley, M.A. 1997: Tachykinin actions on deep dorsal horn neurons in vitro: an electrophysiological and morphological study in the immature rat. European Journal of Neuroscience 9(5): 1037-1046
Brunelleschi, S.; Guidotto, S.; Viano, I.; Fantozzi, R.; Pozzi, E.; Ghio, P.; Albera, C. 1996: Tachykinin activation of human alveolar macrophages in tobacco smoke and sarcoidosis: A phenotypical and functional study. Neuropeptides 30(5): 456-464
Honda, I.; Kohrogi, H.; Yamaguchi, T.; Hamamoto, J.; Hirata, N.; Iwagoe, H.; Fujii, K.; Goto, E.; Ando, M. 1997: Tachykinin antagonist FK224 inhibits neurokinin A-, substance P- and capsaicin-induced human bronchial contraction. Fundamental and Clinical Pharmacology 11(3): 260-266
Joos, G.F.; Kips, J.C.; Peleman, R.A.; Pauwels, R.A. 1995: Tachykinin antagonists and the airways. Archives Internationales de Pharmacodynamie et de Therapie 329(1): 205-219
Cragg, P.A.; Runold, M.; Kou, Y.R.; Prabhakar, N.R. 1994: Tachykinin antagonists in carotid body responses to hypoxia and substance P in the rat. Respiration Physiology 95(3): 295-310
Meini, S.; Mak, J.C.; Rohde, J.A.; Rogers, D.F. 1993: Tachykinin control of ferret airways: mucus secretion, bronchoconstriction and receptor mapping. Neuropeptides 24(2): 81-89
Ishizuka, O.; Mattiasson, A.; Andersson, K.E. 1995: Tachykinin effects on bladder activity in conscious normal rats. Journal of Urology 154(1): 257-261
Urban, L.; Naeem, S.; Patel, I.A.; Dray, A. 1994: Tachykinin induced regulation of excitatory amino acid responses in the rat spinal cord in vitro. Neuroscience Letters 168(1-2): 185-188
Nalivaiko, E.; Michaud, J.C.; Soubrié, P.; Le Fur, G.; Feltz, P. 1997: Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: An in vitro electrophysiological study. Neuroscience 78(3): 745-757
Sarosi, G.A.; Kimball, B.C.; Barnhart, D.C.; Zhang, W.; Mulholland, M.W. 1998: Tachykinin neuropeptide-evoked intracellular calcium transients in cultured guinea pig myenteric neurons. Peptides 19(1): 75-84
Sagan, S.; Chassaing, G.; Pradier, L.; Lavielle, S. 1996: Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. Journal of Pharmacology and Experimental Therapeutics 276(3): 1039-1048
Advenier, C.; Emonds-Alt, X. 1996: Tachykinin receptor antagonists and cough. Pulmonary Pharmacology 9(5-6): 329-333
Solway, J.; Kao, B.M.; Jordan, J.E.; Gitter, B.; Rodger, I.W.; Howbert, J.J.; Alger, L.E.; Necheles, J.; Leff, A.R.; Garland, A. 1993: Tachykinin receptor antagonists inhibit hyperpnea-induced bronchoconstriction in guinea pigs. Journal of Clinical Investigation 92(1): 315-323
Maggi, C.A.; Catalioto, R.M.; Criscuoli, M.; Cucchi, P.; Giuliani, S.; Lecci, A.; Lippi, A.; Meini, S.; Patacchini, R.; Renzetti, A.R.; Santicioli, P.; Tramontana, M.; Zagorodnyuk, V.; Giachetti, A. 1997: Tachykinin receptors and intestinal motility. Canadian Journal of Physiology and Pharmacology 75(6): 696-703
Yuan, L.; Burcher, E.; Nail, B. 1996: Tachykinin receptors and non-cholinergic bronchoconstriction in the anaesthetized guinea-pig. Clinical and Experimental Pharmacology and Physiology 23(2): 119-124
Patacchini, R.; Maggi, C.A. 1995: Tachykinin receptors and receptor subtypes. Archives Internationales de Pharmacodynamie et de Therapie 329(1): 161-184
Burcher, E.; Zeng, X.P.; Strigas, J.; Geraghty, D.P.; Lavielle, S. 1995: Tachykinin receptors in guinea-pig airways: characterization using selective ligands. Canadian Journal of Physiology and Pharmacology 73(7): 915-922
Black, J.L.; Diment, L.M.; Alouan, L.A.; Johnson, P.R.; Armour, C.L.; Badgery-Parker, T.; Burcher, E. 1992: Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies. British Journal of Pharmacology 107(2): 429-436
Burcher, E.; Warner, F.J. 1998: Tachykinin receptors in the small intestine of the cane toad (Bufo marinus): A radioligand binding and functional study. Naunyn-Schmiedeberg's Archives of Pharmacology 357(6): 692-700
Smits, G.J.; Lefebvre, R.A. 1994: Tachykinin receptors involved in the contractile effect of the natural tachykinins in the rat gastric fundus. Journal of Autonomic Pharmacology 14(6): 383-392
Giuliani, S.; Tramontana, M.; Lecci, A.; Maggi, C.A. 1996: Tachykinin receptors mediate atropine-resistant rat duodenal reflex contractions in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 354(3): 327-335
Killingsworth, C.R.; Shore, S.A. 1995: Tachykinin receptors mediating contraction of guinea pig lung strips. Regulatory Peptides 57(2): 149-161
Heavey, M.L.; Lan, W.A.; Pennefather, J.N. 1997: Tachykinin receptors mediating non-cholinergic contraction of the guinea-pig isolated main bronchus in response to field stimulation. Clinical and Experimental Pharmacology and Physiology 24(9-10): 673-679
Hall, J.M.; Mitchell, D.; Morton, I.K. 1993: Tachykinin receptors mediating responses to sensory nerve stimulation and exogenous tachykinins and analogues in the rabbit isolated iris sphincter. British Journal of Pharmacology 109(4): 1008-1013
Shinkai, M.; Takayanagi, I.; Kato, T. 1993: Tachykinin receptors of the NK2 type involved in the acetylcholine release by nicotine in guinea-pig bladder. British Journal of Pharmacology 108(3): 759-762
Guo, J.Z.; Yoshioka, K.; Hosoki, R.; Otsuka, M. 1997: Tachykinin receptors on motoneurons in the spinal cords of neonatal rats, gerbils and hamsters. Neuropeptides 31(5): 495-501
Noveral, J.P.; Grunstein, M.M. 1995: Tachykinin regulation of airway smooth muscle cell proliferation. American Journal of Physiology 269(3 Part 1): L339-L343
Sivam, S.P.; Krause, J.E. 1992: Tachykinin systems in the spinal cord and basal ganglia: Influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA. Journal of Neurochemistry 59(6): 2278-2284
Elekes, K.; Hernádi, L.; Kiss, T.; Muneoka, Y.; Nássel, D.R. 1995: Tachykinin- and leucokinin-related peptides in the molluscan nervous system. Acta Biologica Hungarica 46(2-4): 281-294
Lundquist, C.T.; Brodin, E.; Muren, J.E.; Nässel, D.R. 1993: Tachykinin- and leucokinin-related peptides in the nervous system of the blowfly: immunocytochemical and chromatographical diversity. Peptides 14(4): 651-663
Hayes, R.G.; Shaw, C.; Chakravarthy, U.; Buchanan, K.D. 1993: Tachykinin-1 gene products in porcine ocular tissues: Evidence for transcriptional and post-translational regulation. Vision Research 33(11): 1477-1480
Ellis, J.L.; Sham, J.S.; Undem, B.J. 1997: Tachykinin-independent effects of capsaicin on smooth muscle in human isolated bronchi. American Journal of Respiratory and Critical Care Medicine 155(2): 751-755
Hardwick, J.C.; Mawe, G.M.; Parsons, R.L. 1997: Tachykinin-induced activation of non-specific cation conductance via NK3 neurokinin receptors in guinea-pig intracardiac neurones. Journal of Physiology 504: 65-74
Magoul, R.; Tramu, G. 1997: Tachykinin-induced changes in beta-endorphin gene expression in the rat arcuate nucleus. Neuroscience Letters 223(2): 93-96
Suzuki, N.; Mizuno, K.; Gomi, Y. 1994: Tachykinin-induced contractions in the circular muscle of guinea pig ileum. Japanese Journal of Pharmacology 65(3): 233-240
Vilain, P.; Emonds-Alt, X.; Le Fur, G.; Brelière, J.C. 1997: Tachykinin-induced contractions of the guinea pig ileum longitudinal smooth muscle: Tonic and phasic muscular activities. Canadian Journal of Physiology and Pharmacology 75(6): 587-590
Stroff, T.; Plate, S.; Ebrahim, J.S.; Ehrlich, K.H.; Respondek, M.; Peskar, B.M. 1996: Tachykinin-induced increase in gastric mucosal resistance: role of primary afferent neurons, CGRP, and NO. American Journal of Physiology 271(6 Pt 1): G1017-G1027
Lindell, E.; Svensjö, M.E.; Malm, L.; Petersson, G. 1995: Tachykinin-induced nasal fluid secretion and plasma exudation in the rat: effects of peptidase inhibition. Neuropeptides 28(5): 309-315
Munoz-Chapuli, R.; De-Andres, V.; Ramos, C. 1994: Tachykinin-like immunoreactivity in the sinus venosus of the dogfish (Scyliorhinus canicula). Cell and Tissue Research 278(1): 171-175
Watson, E.G.; Fox-Threlkeld, J.E.; Daniel, E.E. 1994: Tachykinin-mediated increase in motility acts independently of vasoactive intestinal polypeptide release in the canine ileum. Canadian Journal of Physiology and Pharmacology 72(2): 109-112
Kudlacz, E.M.; Logan, D.E.; Shatzer, S.A.; Farrell, A.M.; Baugh, L.E. 1993: Tachykinin-mediated respiratory effects in conscious guinea pigs: modulation by NK1 and NK2 receptor antagonists. European Journal of Pharmacology 241(1): 17-25
Magoul, R.; Onteniente, B.; Benjelloun, W.; Tramu, G. 1993: Tachykinergic afferents to the rat arcuate nucleus. A combined immunohistochemical and retrograde tracing study. Peptides 14(2): 275-286
Julia, V.; Buéno, L. 1997: Tachykininergic mediation of viscerosensitive responses to acute inflammation in rats: role of CGRP. American Journal of Physiology 272(1 Pt 1): G141-G146
Goldhill, J.M.; Shea-Donohue, T.; Ali, N.; Piñeiro-Carrero, V.M. 1997: Tachykinergic neurotransmission is enhanced in small intestinal circular muscle in a rabbit model of inflammation. Journal of Pharmacology and Experimental Therapeutics 282(3): 1373-1378
Otsuka, M. 1995: Tachykininergic signalling and drug development. Folia Pharmacologica Japonica 106(Suppl 1): 1P-4P
Kurihara, T.; Yoshioka, K.; Otsuka, M. 1995: Tachykininergic slow depolarization of motoneurones evoked by descending fibres in the neonatal rat spinal cord. Journal of Physiology 485: 787-796
Magoul, R.; Dubourg, P.; Kah, O.; Tramu, G. 1994: Tachykinergic synaptic inputs to neurons of the medial preoptic region which project to the rat arcuate nucleus. Neuroscience Letters 169(1-2): 149-153
Zhao, F.Y.; Saito, K.; Yoshioka, K.; Guo, J.Z.; Murakoshi, T.; Konishi, S.; Otsuka, M. 1996: Tachykininergic synaptic transmission in the coeliac ganglion of the guinea-pig. British Journal of Pharmacology 118(8): 2059-2066
Houghton, A.K.; Gorringe, C.M.; Clarke, R.W. 1995: Tachykininergic tone in the spinal cord of the rabbit: Dependence on nociceptive input arising from invasive surgery. Neuroscience 69(1): 241-248
Conlon, J.M.; Adrian, T.E.; Secor, S.M. 1997: Tachykinins (substance P, neurokinin A and neuropeptide gamma) and neurotensin from the intestine of the Burmese python, Python molurus. Peptides 18(10): 1505-1510
Waugh, D.; Bondareva, V.; Rusakov, Y.; Bjenning, C.; Nielsen, P.F.; Conlon, J.M. 1995: Tachykinins With Unusual Structural Features From a Urodele, the Amphiuma, an Elasmobranch, the Hammerhead Shark, and an Agnathan, the River Lamprey. Peptides 16(4): 615-621
Lee, H.K.; Shuttleworth, C.W.; Sanders, K.M. 1995: Tachykinins activate nonselective cation currents in canine colonic myocytes. American Journal of Physiology 269(6 Pt 1): C1394-C1401
Parsons, A.M.; el-Fakahany, E.E.; Seybold, V.S. 1995: Tachykinins alter inositol phosphate formation, but not cyclic AMP levels, in primary cultures of neonatal rat spinal neurons through activation of neurokinin receptors. Neuroscience 68(3): 855-865
Monteau, R.; Ptak, K.; Broquère, N.; Hilaire, G. 1996: Tachykinins and central respiratory activity: an in vitro study on the newborn rat. European Journal of Pharmacology 314(1-2): 41-50
Ricciardolo, F.L.; Nadel, J.A.; Bertrand, C.; Yamawaki, I.; Chan, B.; Geppetti, P. 1994: Tachykinins and kinins in antigen-evoked plasma extravasation in guinea-pig nasal mucosa. European Journal of Pharmacology 261(1-2): 127-132
Mignogna, G.; Severini, C.; Erspamer, G.F.; Siciliano, R.; Kreil, G.; Barra, D. 1997: Tachykinins and other biologically active peptides from the skin of the Costa Rican phyllomedusid frog Agalychnis callidryas. Peptides 18(3): 367-372
Giuliani, S.; Lecci, A.; Giachetti, A.; Maggi, C.A. 1993: Tachykinins and reflexly evoked atropine-resistant motility in the guinea pig colon in vivo. Journal of Pharmacology and Experimental Therapeutics 265(3): 1224-1231
Mawe, G.M. 1995: Tachykinins as mediators of slow EPSPs in guinea-pig gall-bladder ganglia: involvement of neurokinin-3 receptors. Journal of Physiology 485: 513-524
Akasu, T.; Ishimatsu, M.; Yamada, K. 1996: Tachykinins cause inward current through NK1 receptors in bullfrog sensory neurons. Brain Research 713(1-2): 160-167
Huber, O.; Bertrand, C.; Bunnett, N.W.; Pellegrini, C.A.; Nadel, J.A.; Debas, H.T.; Geppetti, P. 1993: Tachykinins contract the circular muscle of the human esophageal body in vitro via NK2 receptors. Gastroenterology 105(4): 981-987
Joos, G.F.; Lefebvre, R.A.; Kips, J.C.; Pauwels, R.A. 1994: Tachykinins contract trachea from Fischer 344 rats by interaction with a tachykinin NK1 receptor. European Journal of Pharmacology 271(1): 47-54
Matheson, M.J.; Rynell, A.C.; McClean, M.A.; Berend, N. 1997: Tachykinins do not cause plasma leakage in the rabbit trachea. Respiration Physiology 108(2): 165-170
Lin, C.W.; Lai, Y.L. 1998: Tachykinins in propranolol-augmented, hyperpnoea-induced bronchoconstriction in Taida guinea-pigs: Effects of dimethylthiourea. Journal of Autonomic Pharmacology 18(3): 139-147
Zilov, V.G. 1992: Tachykinins in the central mechanisms of biological motivation. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1992(7): 54-57
Debeljuk, L.; Arce, A.; Garcia Bonacho, M.; Bartke, A.; Esquifino, A.I. 1998: Tachykinins in the pineal gland: effect of castration and ganglionectomy. Peptides 19(6): 1073-1078
Lördal, M.; Hällgren, A.; Nylander, O.; Hellström, P.M. 1996: Tachykinins increase vascular permeability in the gastrointestinal tract of the rat. Acta Physiologica Scandinavica 156(4): 489-494
D'Ortho, M.P.; Jarreau, P.H.; Delacourt, C.; Pezet, S.; Lafuma, C.; Harf, A.; Macquin-Mavier, I. 1995: Tachykinins induce gelatinase production by guinea pig alveolar macrophages: involvement of NK2 receptors. American Journal of Physiology 269(5 Pt 1): L631-L636
Lördal, M.; Theodorsson, E.; Hellström, P.M. 1997: Tachykinins influence interdigestive rhythm and contractile strength of human small intestine. Digestive Diseases and Sciences 42(9): 1940-1949
Maubach, K.A.; Cody, C.; Jones, R.S. 1998: Tachykinins may modify spontaneous epileptiform activity in the rat entorhinal cortex in vitro by activating gabaergic inhibition. Neuroscience 83(4): 1047-1062
Huber, O.; Bertrand, C.; Bunnett, N.W.; Pellegrini, C.A.; Nadel, J.A.; Nakazato, P.; Debas, H.T.; Geppetti, P. 1993: Tachykinins mediate contraction of the human lower esophageal sphincter in vitro via activation of NK2 receptors. European Journal of Pharmacology 239(1-3): 103-109
Rusin, K.I.; Bleakman, D.; Chard, P.S.; Randic, M.; Miller, R.J. 1993: Tachykinins potentiate N-methyl-D-aspartate responses in acutely isolated neurons from the dorsal horn. Journal of Neurochemistry 60(3): 952-960
Calvo, N.; Reiriz, J.; Pérez-Navarro, E.; Alberch, J. 1996: Tachykinins protect cholinergic neurons from quinolinic acid excitotoxicity in striatal cultures. Brain Research 740(1-2): 323-328
Lördal, M.; Söder, O.; Hellström, P.M. 1997: Tachykinins stimulate lipid peroxidation mediated by free radicals in gastrointestinal tract of rat. Digestive Diseases and Sciences 42(7): 1524-1529
Tamaoki, J.; Kondo, M.; Sakai, A.; Tagaya, E.; Takemura, H.; Konno, K. 1995: Tachykinins stimulate nitric oxide generation by canine cultured tracheal epithelium. Regulatory Peptides 60(1): 55-60
Khawaja, A.M.; Rogers, D.F. 1996: Tachykinins: Receptor to effector. International Journal of Biochemistry and Cell Biology 28(7): 721-738
Miao, F.J.; Khasar, S.G.; Green, P.G.; Levine, J.D. 1996: Tachyphylaxis develops to bradykinin-induced plasma extravasation in the rat. Neuroscience Letters 208(2): 143-145
Smith, T.L.; Callahan, M.; Williams, D.; Dworkin, S.I. 1993: Tachyphylaxis in cardiovascular responses to cocaine in conscious rats. Journal of Cardiovascular Pharmacology 21(2): 272-278
Stein, C.M.; Nelson, R.; Deegan, R.; He, H.; Inagami, T.; Frazer, M.; Badr, K.F.; Wood, M.; Wood, A.J. 1995: Tachyphylaxis of human forearm vascular responses does not occur rapidly after exposure to isoproterenol. Hypertension 25(6): 1294-1300
Eich-Rathfelder, S.; Whalley, E.T.; Fautz, M.; Hohenbleicher, F.; Fritz, H.; Siebeck, M. 1997: Tachyphylaxis of the B1 kinin receptor in porcine endotoxin shock. Immunopharmacology 36(2-3): 173-177
Iwamoto, L.M.; Wilson, V.L.; Lavallee, S.L.; Fujiwara, N.; Ayau, E.L.; Nakamura, K.T. 1996: Tachyphylaxis to furosemide in isolated airways of guinea pigs. Life Sciences 59(13): 1015-1024
Singh, S.; Gupta, A.; Pandey, S.S.; Singh, G. 1996: Tachyphylaxis to histamine-induced wheal suppression by topical 0.05 percent clobetasol propionate in normal versus Croton oil-induced dermatitic skin. Dermatology (Basel) 193(2): 121-123
Hollenberg, S.M.; Shelhamer, J.H.; Cunnion, R.E. 1993: Tachyphylaxis to the vasopressor effects of endothelin in rat aortic rings. American Journal of Physiology 264(2 Part 2): H352-H356
Schulke, M. 1995: Tachyporus lohsei sp. nov., the first species of the genus from Southern China (Coleoptera, Staphylinidae): 16th contribution to the knowledge of Tachyporinae. Entomologische Blätter für Biologie und Systematik der Käfer 91(3): 142-148
Schuelke, M. 1993: Tachyporus obscurellus Zetterstedt recorded in Central Europe (Coleoptera: Stapylinidae): 12. Contribution to the knowledge of Tachyporinae. Entomologische Blätter für Biologie und Systematik der Käfer 89(1-2): 71-74
Warwick, T.; Tsang, E.P.K. 1995: Tackling car sequencing problems using a generic genetic algorithm. Evolutionary Computation 3(3): 267-298
Stenkula, S.; Byhr, E.; Crafoord, S.; Carlsson, J.O.; Jemt, M.; Shanks, G.; Stenevi, U. 1998: Tackling the "dropped nucleus". Acta Ophthalmologica Scandinavica 76(2): 220-223
Bushby, P.A. 1994: Tackling the knowledge explosion without overloading the student. Australian Veterinary Journal 71(11): 372-374
Davis, K.L.; Powchik, P. 1995: Tacrine. Lancet 345(8950): 625-630
Lahiri, D.K.; Lewis, S.; Farlow, M.R. 1994: Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines. Journal of Neuroscience Research 37(6): 777-787
Watkins, P.B. 1994: Tacrine and transaminases. Alzheimer Disease and Associated Disorders 8(Suppl 2): S32-S38
Schneider, L.S. 1994: Tacrine development experience: Early clinical trials and enrichment and parallel designs. Alzheimer Disease and Associated Disorders 8(Suppl 2): S12-S21
Ibebunjo, C.; Eshelby, D.; Donati, F.; Fox, G.S.; Tchervenkov, J.I. 1997: Tacrine does not alter the potency of succinylcholine in the rat. Canadian Journal of Anaesthesia 44(9): 1021-1026
Lebert, F.; Pasquier, F.; Souliez, L.; Petit, H. 1998: Tacrine efficacy in Lewy body dementia. International Journal of Geriatric Psychiatry 13(8): 516-519
Suzuki, T.; Nonaka, H.; Fujimoto, K.; Kawashima, K. 1994: Tacrine increases stimulation-evoked acetylcholine release from rat hippocampal slices. Japanese Journal of Pharmacology 65(4): 337-342
Sugawara, T.; Ohta, T.; Asano, T.; Ito, S.; Nakazato, Y. 1997: Tacrine inhibits nicotinic secretory and current responses in adrenal chromaffin cells. European Journal of Pharmacology 319(1): 123-130
Rees, S.A.; Curtis, M.J. 1993: Tacrine inhibits ventricular fibrillation induced by ischaemia and reperfusion and widens QT interval in rat. Cardiovascular Research 27(3): 453-458
Augry, F.; Darchy, A.; De-Rotrou, J.; Guelfi, M.C.; Forette, F. 1997: Tacrine response: Review of two years of prescription. Journal de Pharmacie Clinique 16(3): 183-187
Nordberg, A.; Lilja, A.; Lundqvist, H.; Hartvig, P.; Amberla, K.; Viitanen, M.; Warpman, U.; Johansson, M.; Hellström-Lindahl, E.; Bjurling, P. 1992: Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiology of Aging 13(6): 747-758
Park, B.K.; Madden, S.; Spaldin, V.; Woolf, T., F.; Pool, W., F. 1994: Tacrine transaminitis: Potential mechanisms. Alzheimer Disease and Associated Disorders 8(Suppl 2): S39-S49
Cantí, C.; Martí, E.; Marsal, J.; Solsona, C. 1994: Tacrine-induced increase in the release of spontaneous high quantal content events in Torpedo electric organ. British Journal of Pharmacology 112(1): 19-22
Crismon, M.L. 1994: Tacrine: first drug approved for Alzheimer's disease. Annals of PharmacoTherapy 28(6): 744-751
Bader, A.; Knop, E.; Böker, K.H.; Crome, O.; Frühauf, N.; Gonschior, A.K.; Christians, U.; Esselmann, H.; Pichlmayr, R.; Sewing, K.F. 1996: Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry. Naunyn-Schmiedeberg's Archives of Pharmacology 353(4): 461-473
Mrvos, R.; Hodgman, M.; Krenzelok, E.P. 1997: Tacrolimus (FK 506) overdose: a report of five cases. Journal of Toxicology. Clinical Toxicology 35(4): 395-399
Van Thiel, D.H.; Carroll, P.; Abu-Elmagd, K.; Rodriguez-Rilo, H.; Irish, W.; McMichael, J.; Starzl, T.E. 1995: Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. American Journal of Gastroenterology 90(3): 455-459
Nash, R.A.; Etzioni, R.; Storb, R.; Furlong, T.; Gooley, T.; Anasetti, C.; Appelbaum, F.R.; Doney, K.; Martin, P.; Slattery, J. 1995: Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study. Blood 85(12): 3746-3753
Eckhoff, D.E.; McGuire, B.M.; Frenette, L.R.; Contreras, J.L.; Hudson, S.L.; Bynon, J.S. 1998: Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. Transplantation 65(2): 180-187
Tsujikawa, A.; Ogura, Y.; Hiroshiba, N.; Miyamoto, K.; Kiryu, J.; Honda, Y. 1998: Tacrolimus (FK506) attenuates leukocyte accumulation after transient retinal ischemia. Stroke 29(7): 1431-7; Discussion 1437-8
Garcia-Criado, F.J.; Palma-Vargas, J.M.; Valdunciel-Garcia, J.J.; Toledo, A.H.; Misawa, K.; Gomez-Alonso, A.; Toledo-Pereyra, L.H. 1997: Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. Transplantation 64(4): 594-598